US20030152547A1 - Anionic-cationic polyion complexes comprising zwitterionic monomer component - Google Patents
Anionic-cationic polyion complexes comprising zwitterionic monomer component Download PDFInfo
- Publication number
- US20030152547A1 US20030152547A1 US10/341,565 US34156503A US2003152547A1 US 20030152547 A1 US20030152547 A1 US 20030152547A1 US 34156503 A US34156503 A US 34156503A US 2003152547 A1 US2003152547 A1 US 2003152547A1
- Authority
- US
- United States
- Prior art keywords
- groups
- group
- cationic
- monomer
- anionic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000178 monomer Substances 0.000 title claims abstract description 94
- 229920000831 ionic polymer Polymers 0.000 title claims abstract description 55
- 229920000642 polymer Polymers 0.000 claims abstract description 71
- 125000002091 cationic group Chemical group 0.000 claims abstract description 61
- 125000000129 anionic group Chemical group 0.000 claims abstract description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 36
- 150000003839 salts Chemical class 0.000 claims abstract description 19
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 10
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 8
- 239000010452 phosphate Substances 0.000 claims abstract description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 6
- 239000002904 solvent Substances 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 34
- 229910052739 hydrogen Inorganic materials 0.000 claims description 28
- 239000001257 hydrogen Substances 0.000 claims description 28
- 229920006318 anionic polymer Polymers 0.000 claims description 27
- 229920006317 cationic polymer Polymers 0.000 claims description 27
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- SNVLJLYUUXKWOJ-UHFFFAOYSA-N methylidenecarbene Chemical compound C=[C] SNVLJLYUUXKWOJ-UHFFFAOYSA-N 0.000 claims description 20
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 17
- 229910052757 nitrogen Inorganic materials 0.000 claims description 17
- 125000004432 carbon atom Chemical group C* 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 11
- 125000004429 atom Chemical group 0.000 claims description 10
- 238000012360 testing method Methods 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 125000005843 halogen group Chemical group 0.000 claims description 7
- 239000003960 organic solvent Substances 0.000 claims description 7
- -1 diallyl dialkyl ammonium halide Chemical class 0.000 claims description 6
- 125000000623 heterocyclic group Chemical group 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical compound [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000001153 fluoro group Chemical group F* 0.000 claims description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000000524 functional group Chemical group 0.000 claims description 4
- 230000010355 oscillation Effects 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- 239000013543 active substance Substances 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 claims description 3
- 150000007942 carboxylates Chemical class 0.000 claims description 3
- 229940039227 diagnostic agent Drugs 0.000 claims description 3
- 239000000032 diagnostic agent Substances 0.000 claims description 3
- 150000002431 hydrogen Chemical class 0.000 claims description 3
- 150000002576 ketones Chemical class 0.000 claims description 3
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims description 3
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 claims description 3
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 claims description 3
- 229910021653 sulphate ion Inorganic materials 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- NJSSICCENMLTKO-HRCBOCMUSA-N [(1r,2s,4r,5r)-3-hydroxy-4-(4-methylphenyl)sulfonyloxy-6,8-dioxabicyclo[3.2.1]octan-2-yl] 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)O[C@H]1C(O)[C@@H](OS(=O)(=O)C=2C=CC(C)=CC=2)[C@@H]2OC[C@H]1O2 NJSSICCENMLTKO-HRCBOCMUSA-N 0.000 claims description 2
- 125000004442 acylamino group Chemical group 0.000 claims description 2
- 125000004423 acyloxy group Chemical group 0.000 claims description 2
- 125000005275 alkylenearyl group Chemical group 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 2
- 150000002500 ions Chemical class 0.000 claims description 2
- 229910021645 metal ion Inorganic materials 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 abstract 1
- 230000009969 flowable effect Effects 0.000 abstract 1
- 208000036758 Postinfectious cerebellitis Diseases 0.000 description 54
- 101150086837 pic gene Proteins 0.000 description 53
- 239000000243 solution Substances 0.000 description 40
- 239000000499 gel Substances 0.000 description 39
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 15
- 150000001450 anions Chemical class 0.000 description 13
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 12
- 239000007787 solid Substances 0.000 description 12
- 238000000576 coating method Methods 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane Natural products ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 10
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 8
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 8
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- 0 [5*][N+]([5*])(C)C Chemical compound [5*][N+]([5*])(C)C 0.000 description 7
- 150000001768 cations Chemical class 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 229920000139 polyethylene terephthalate Polymers 0.000 description 7
- 239000005020 polyethylene terephthalate Substances 0.000 description 7
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000007810 chemical reaction solvent Substances 0.000 description 5
- 238000001879 gelation Methods 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 125000001165 hydrophobic group Chemical group 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 102000008946 Fibrinogen Human genes 0.000 description 4
- 108010049003 Fibrinogen Proteins 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229940012952 fibrinogen Drugs 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 238000010587 phase diagram Methods 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 229920000447 polyanionic polymer Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 206010002329 Aneurysm Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000001772 blood platelet Anatomy 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 238000002731 protein assay Methods 0.000 description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- KKUKTXOBAWVSHC-UHFFFAOYSA-M COP(=O)([O-])OC Chemical compound COP(=O)([O-])OC KKUKTXOBAWVSHC-UHFFFAOYSA-M 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000006957 Michael reaction Methods 0.000 description 2
- IZWSFJTYBVKZNK-UHFFFAOYSA-O N-dodecyl-N,N-dimethyl-3-ammonio-1-propanesulfonic acid Chemical compound CCCCCCCCCCCC[N+](C)(C)CCCS(O)(=O)=O IZWSFJTYBVKZNK-UHFFFAOYSA-O 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- AFYNADDZULBEJA-UHFFFAOYSA-N bicinchoninic acid Chemical compound C1=CC=CC2=NC(C=3C=C(C4=CC=CC=C4N=3)C(=O)O)=CC(C(O)=O)=C21 AFYNADDZULBEJA-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000008199 coating composition Substances 0.000 description 2
- 238000010668 complexation reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical group C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000000518 rheometry Methods 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- OXJGJKIURHREKH-UHFFFAOYSA-O CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C Chemical compound CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C OXJGJKIURHREKH-UHFFFAOYSA-O 0.000 description 1
- WISLCSRPNCZQQC-UHFFFAOYSA-M CCP(=O)([O-])C[W+] Chemical compound CCP(=O)([O-])C[W+] WISLCSRPNCZQQC-UHFFFAOYSA-M 0.000 description 1
- RZTRBKVMXIUWBG-UHFFFAOYSA-M CP(=O)([O-])C[W+] Chemical compound CP(=O)([O-])C[W+] RZTRBKVMXIUWBG-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical group S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N Ic1ccccc1 Chemical compound Ic1ccccc1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- YUWBVKYVJWNVLE-UHFFFAOYSA-N [N].[P] Chemical compound [N].[P] YUWBVKYVJWNVLE-UHFFFAOYSA-N 0.000 description 1
- QCJQWJKKTGJDCM-UHFFFAOYSA-N [P].[S] Chemical compound [P].[S] QCJQWJKKTGJDCM-UHFFFAOYSA-N 0.000 description 1
- OZGWAEVZOTWYRA-UHFFFAOYSA-N [S].CCCOC(=O)C(C)=C Chemical compound [S].CCCOC(=O)C(C)=C OZGWAEVZOTWYRA-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 238000012925 biological evaluation Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- YDVNLQGCLLPHAH-UHFFFAOYSA-N dichloromethane;hydrate Chemical compound O.ClCCl YDVNLQGCLLPHAH-UHFFFAOYSA-N 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000008393 encapsulating agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- 230000008863 intramolecular interaction Effects 0.000 description 1
- 125000003010 ionic group Chemical group 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000013627 low molecular weight specie Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- COTNUBDHGSIOTA-UHFFFAOYSA-N meoh methanol Chemical compound OC.OC COTNUBDHGSIOTA-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000001453 nonthrombogenic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 208000003278 patent ductus arteriosus Diseases 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 125000005496 phosphonium group Chemical group 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- PYJNAPOPMIJKJZ-UHFFFAOYSA-N phosphorylcholine chloride Chemical compound [Cl-].C[N+](C)(C)CCOP(O)(O)=O PYJNAPOPMIJKJZ-UHFFFAOYSA-N 0.000 description 1
- 229920002851 polycationic polymer Polymers 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- PNOXUQIZPBURMT-UHFFFAOYSA-M potassium;3-(2-methylprop-2-enoyloxy)propane-1-sulfonate Chemical compound [K+].CC(=C)C(=O)OCCCS([O-])(=O)=O PNOXUQIZPBURMT-UHFFFAOYSA-M 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K9/00—Use of pretreated ingredients
- C08K9/12—Adsorbed ingredients, e.g. ingredients on carriers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L57/00—Compositions of unspecified polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C08L57/04—Copolymers in which only the monomer in minority is defined
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L57/00—Compositions of unspecified polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C08L57/06—Homopolymers or copolymers containing elements other than carbon and hydrogen
- C08L57/12—Homopolymers or copolymers containing elements other than carbon and hydrogen containing nitrogen atoms
Definitions
- the present invention relates to polyion complexes, that is intimate blends of overall cationic polymers and overall anionic polymers, at least one of which said polymers has pendant zwitterionic groups to provide improved biocompatibility.
- Physical gels are three-dimensional, disordered networks formed by associative forces that initiate noncovalent crosslinks. Mechanisms of interaction are numerous, including hydrogen bonding, hydrophobic interactions, crystalline segment formation and ionic association amongst others (Tanaka & Edwards, Macromolecules, 25, 1516, 1992).
- Another method of obtaining a gel by complexation of relevance to this invention is by the formation of an interpolymer complex.
- this is a process by which two distinct polymer entities interact to form a complex. If complexation is achieved by the interaction of oppositely charged ionic groups within the two polymers, the system is termed a polyion or polyelectrolyte complex (Michaels, Indust. & Eng. Chemistry, 57 32, 1965).
- the polyion complexes have the potential to be solubilised in ternary solvent systems consisting of water, a water-soluble organic solvent like acetone and a strongly ionised simple electrolyte such as NaBr. This allows fabrication into many forms including fibres, films and coatings. This, together with their reported inherent non-thrombogenic nature, has made these materials interesting as biomaterials (Ratner & Hoffman, ACS Symposium Series 71 ed. J. D. Andrade, ACS, Washington D.C., 1976, p1).
- Ioplex 101 a complex poly(triethyl-(3 & 4)-vinylphenylammonium bromide) and poly(sodium vinyl benzenesulphonate)
- Ioplex 101 has been examined intensively for biomedical usage (Vogel el al. J. MacromoL Sci., Chem., 4, 675, 1970; Marshall et al., J. Biomed Mater. Res., 4, 357,1970; Bruck et al., Ann.
- MPC 2-methacroyoyloxyethyl phosphorylcholine
- BMA butyl methacrylate
- SPM sulfur propyl methacrylate
- TPM trimethyl anmmonium propyl methacrylate
- the anionic and cationic polymers are water insoluble, alcohol soluble.
- the polyion complexes described in these references are tested as coatings on glass beads and one of the products is said to be under test for use to encapsulate activated charcoal used for an artificial liver support system.
- Coatings of the PIC's are produced by mixing preformed solutions at 10% solids concentrations of the terpolymers each in ethanol, dipping the substrate to be coated in the solution and allowing the alcohol to evaporate from the film of coating composition.
- JP-A-08-165491 (1996) describes complexes formed of a polymer having an overall cationic charge and which further includes pendant hydrophobic groups and pendant carboxybetaine groups, with an anionic surfactant such as ⁇ -olefin sulphonates and fatty acid soaps.
- the complexes are flexible solids and are for use with detergent components.
- JP-A-10-245325 (1998) describeshair setting compositions comprising a cationic polymer having pendant hydrophobic groups, and a polymer having pendant carboxybetaine groups and pendant hydrophobic groups.
- a new method in which a solution of an anionic polymer having an overall anionic charge and a cationic polymer having an overall cationic charge together in a solvent system comprising a first solvent and an inorganic salt, in solution, is gelled by contact with water, whereby the ions of the inorganic salts become dissociated from the polymer and extracted from the gel formed by electrostatic attraction between polymer bound cationic groups and polymer bound anionic groups, and is characterised in that at least one of the cationic and anionic polymers comprises zwitterionic groups.
- the method of the invention thus involves a transformation of the polymer from being in a mobile solution or suspension form to being a gel.
- the method generally involves collapsing of the gel, that is the gel has a lower volume than the starting volume of the solution in the solvent system.
- the solvent system generally comprises an organic solvent.
- the organic solvent is water-miscible.
- the solvent system comprises at least two solvents, in which the second solvent is water.
- Suitable organic solvents for use in the solvent systems are alcohols, ethers, esters and, most preferably, ketones. Most preferably the solvent is a ketone such as acetone.
- a solvent system comprising two solvents, these are generally used in a ratio in the range 5:1 to 1:5.
- the range of organic solvent water is in the range 2:1 to 1:5, preferably 1:1 to 1:4.
- the inorganic salts should be soluble in the solvent system. Where the solvent system contains water, therefore, the salt should be water-soluble, for instance at a concentration of at least 10% by weight. Preferably the salt is soluble in a concentration of at least 20% by weight.
- the salt comprises a single, preferably monovalent metal salt. Di- or higher valent metal salts may cause premature coagulation or gelation.
- the anion of the salt is preferably a sinly charged anion, preferably of a strong acid, most preferably other than an oxyanion although some oxyanions may be useful.
- the anion is a halide.
- the salt is preferably a halide of an alkali metal.
- the alkali metal is lithium, potassium, or, preferably, sodium.
- the halide is suitably chloride, bromide or iodide.
- the salt is preferably present in the solvent system in an amount of at least 2% by weight, preferably at least 5% by weight, for instance up to 20%/ by weight. Preferably the salt is present in an amount in the range 5 to 15% by weight.
- the polymer bound cationic and anionic groups may comprise charged atoms in the backbone of the molecule.
- Cationic groups formed in the backbone of the polymer may, for instance, be secondary, tertiary or quaternary ammonium groups.
- the cationic and anionic groups ofthe polymers are pendant groups.
- the zwitterionic monomer is preferably a pendant group.
- the individual polymers used in the method of the invention are preferably water-soluble, for instance produce a clear solution at a concentration of at least 1%, more preferably at least 5%, by weight.
- the mixed solution of the two polymers in the solvent system may be generated by mixing together preformed solutions of the individual polymers in portions of the solvent system, or components thereof. It is generally preferred that all of the components are present in combination when the polymers first contact one another, in order to avoid premature gelling. Mixing procedures generally involve adequate stirring and temperatures which provide the desired solubility.
- the individual polymers may be of low or high molecular weight.
- the molecular weight is low enough for the solution of the individual monomer in a single solvent to be mobile and of low viscosity, to optimise handling.
- the inherent viscosity of the polymer solutions according to the test provided hereinafter is in the range 5 to 500 mPa.s, more preferably in the range 10 to 300 mPa.s, for instance in the range 20 to 150 mPa.s.
- both of the polymers have zwitterionic groups, preferably zwitterionic pendant groups. It is preferred for the zwitterionic group to comprise a monovalent anion and monovalent cation. Where the zwitterion comprises an excess of anion over cation or vice versa, the zwitterionic group may finction as both polymer bound anion or cation, as the case may be, and zwitterion.
- water is contacted with the solution of the mixed polymers in the solvent system by any suitable means.
- the interface of a body of the solution with water may be provided at the surface of a coating on a substrate, or the solution may be restrained in a mould providing means for contacting the solution in the mould with water.
- Liquid excluded from the gel, upon collapse, for instance, may be removed by evaporation or by draining from the gel.
- the water may be contacted with the solution by spraying, flowing or dipping.
- PIC's formed by the new phase change, gelification procedure are novel in themselves. Thus PIC's formed from combinations of certain selected polymers have not been disclosed in the prior art. It may be possible to make the PIC's by alternative processes, such as by depositing them from a mixed solvent system in which they are soluble, followed be evaporation of the solvent, that is using the general procedure described by Ishihara et al., op.cit.
- a new polyion complex according to the present invention is formed from a cationic polymer having an overall cationic charge and an anionic polymer having an overall anionic charge, in which the anionic polymer is obtainable by polymerising ethylenically unsaturated monomers comprising:
- the cationic polymer is obtainable by polymerising ethylenically unsaturated monomers including
- the total units in the polyion complex derivable from nonionic monomer c and f is in the range 0 to 60 mole %
- the total mole % of units in the PIC derivable from zwitterionic monomer is in the range 1 to 70 mole %
- the ratio of moles of anionic or anionisable groups in the anionic polymer to the moles of cationic or cationisable groups in the cationic polymer is in the range 1.5:1 to 1:1. 5.
- a new polyion complex is formed from a cationic polymer having an overall cationic charge and an anionic polymer having an overall anionic charge, in which the anionic polymer is water soluble and is obtainable by polymerising monomers including
- the cationic polymer is water soluble and is obtainable by polymerising ethylenically unsaturated monomers including
- the total level of units derivable from nonionic monomer in the PIC is preferably at least 5 mole %.
- the anionic polymer preferably does not include units derivable from cationic monomer and the cationic polymer preferably does not include units derivable from anionic monomer.
- the components of the PIC in terms of the cationic and anionic polymers and the monomers from which each polymer is made, are generally selected such that an aqueous gel of the novel PIC product of the novel process flows under imposition of the force rendering it capable of being pumped.
- the desired properties are achievable by using relatively high proportions of zwitterionic monomer.
- the total units derivable from zwitterionic monomer in the PIC is preferably at least 30 mole %, generally less than 50 mole %.
- the level ofunits in the PIC derivable from zwitterionic monomer is preferably in the range 15 to 70 mole %.
- the level of units derivable from zwitterionic monomer in the PIC is preferably in the range 70 to 30 mole %.
- the ratio of equivalents of anionic groups in anionic polymer to equivalents of cationic groups in cationic polymer is preferably in the range 1.25:1 to 1:1.25, more preferably in the range 1.1:1 to 1:1. 1, preferably about 1:1.
- the PIC have no overall charge.
- the PIC should generally be water-insoluble, but water-swellable.
- the PIC's may absorb more than their own weight of water, often more than twice their own weight for instance up to 10 times their own weight.
- the rheological properties of the PIC may be determined by using a variable torque oscillation test in a suitable rheometer. Such a device can determine the elasticity modulus and the viscous modulus.
- the present invention is directed in particular to PIC's which, when swollen in water, and subjected to the test as set out in the following paragraph have values of G′ (elasticity modulus) and G′′W (viscous modulus) of G′ in the range 1 to 1000 and G′′ in the range 5 to 1000. Generally the test is conducted when the gels are fully swollen in water.
- the viscoelastic properties are determined using a variable torque oscillation test (80 mN.m) using a TA instrument CSL-100 rheometer fitted with 6cm 2° cone at 37° C.
- the zwitterionic pendant group of the polymer used in the invention may have an overall charge, for instance by having a divalent centre of anionic charge and monovalent centre of cationic charge or vice-versa or by having two centres of cationic charge and one centre of anionic charge or vice-versa.
- the zwitterion has no overall charge and most preferably has a centre of monovalent cationic charge and a centre of monovalent anionic charge.
- the centre of cationic charge in the zwitterionic group is permanent, that is it is preferably a quaternary ammonium or phosphonium or tertiary sulphonium group.
- the anion is permanent, that is it is substantially completely ionised at in vivo pH's, for instance at pH's in the range 5 to 8. It is preferably a phosphate, phosphonate, sulphate or sulphonate anion.
- the zwitterionic group may be a betaine group (ie in which the cation is closer to the backbone), for instance a sulpho-, carboxy- or phospho-betaine.
- a betaine group should have no overall charge and is preferably therefore a carboxy- or sulpho-betaine. If it is a phosphobetaine the phosphate terminal group must be a diester, i.e., be esterified with an alcohol.
- Such groups may be represented by the general formula I
- X 2 is a valence bond, —O—, —S— or —NH—, preferably —O—;
- V is a carboxylate, sulphonate or phosphate diester(monovalently charged) anion
- R 2 is a valence bond (together with X 2 ) or alkanedyl —C(O)alkanediyl— or —C(O)NHalkanediyl preferably alkanediyl and preferably containing from 1 to 6 carbon atoms in the alkanediyl chain;
- the groups R 3 are the same or different and each is hydrogen or alkyl of 1 to 4 carbon atoms or the groups R 3 together with the nitrogen to which they are attached form a heterocyclic ring of 5 to 7 atoms;
- R 4 is alkanediyl of 1 to 20, preferably 1 to 10, more preferably 1 to 6 carbon atoms.
- One preferred sulphobetaine monomer has the formula III
- the groups R 5 are the same. It is also preferable that at least one ofthe groups R 5 is methyl, and more preferable that the groups R 5 are both methyl.
- n is 2 or 3, more preferably 3.
- the zwitterionic group may be an amino acid moiety in which the alpha carbon atom (to which an amine group and the carboxylic acid group are attached) is joined through a linker group to the backbone of polymer A.
- Such groups may be represented by the general formula III
- X 3 is a valence bond, —O—, —S— or —NH—, preferably —O—
- R 6 is a valence bond (optionally together with X 3 ) or alkanediyl, —C(O)alkanediyl— or —C(O)NHalkanediyl, preferably alkanediyl and preferably containing from 1 to 6 carbon atoms;
- the groups R 7 are the same or different and each is hydrogen or alkyl of 1 to 4 carbon atoms, preferably methyl, or two of the groups R 7 , together with the nitrogen to which they are attached, form a heterocyclic ring of from 5 to 7 atoms, or the three group R 7 together with the nitrogen atom to which they are attached form a fused ring structure containing from 5 to 7 atoms in each ring.
- the zwitterion has the formula IV
- moieties X 4 and X 5 which are the same or different, are —O—, —S—, —NH— or a valence bond, preferably —O—, and
- W + is a group comprising an anrnonium, phosphonium or sulphonium cationic group and a group linking the anionic and cationic moieties which is preferably a C 1-12 —alkylene group.
- W contains as cationic group an ammonium group, more preferably a quatemary ammomum group.
- the group W + may for example be a group of formula
- W 1 is alkanediyl of 1 or more, preferably 2-6, carbon atoms optionally containing one or more ethylenically unsaturated double or triple bonds, disubstituted-aryl, alkylene aryl, aryl alkylene, or alkylene aryl alkylene, disubstituted cycloalkyl, alkylene cycloalkyl cycloalkyl alkylene or alkylene cycloalkyl alkylene, which group W 1 optionally contains one or more fluorine substituents and/or one or more functional groups; and
- either the groups R 8 are the same or different and each is hydrogen or alkyl of 1 to 4 carbon atoms, preferably methyl, or aryl, such as phenyl, or two of the groups R 8 together with the nitrogen atom to which they are attached form a heterocyclic ring containing from 5 to 7 atoms or the three groups R 8 together with the nitrogen atom to which they are attached form a fused ring structure containing from 5 to 7 atoms in each ring, and optionally one or more of the groups R 8 is substituted by a hydrophilic functional group, and
- the groups R 9 are the same or different and each is Rs or a group OR 8 , where R 8 is as defined above; or
- Het is an aromatic nitrogen-, phosphorus- or sulphur-, preferably nitrogen-, containing ring, for example pyridine.
- W 1 is a straight-chain alkanediyl group, most preferably 1,2-thanediyl.
- Preferred groups of the formula IV are groups of formula V:
- the groups R 10 are the same. It is also preferable that at least one of the groups R 10 is methyl, and more preferable that the groups R 10 are all methyl.
- m is 2 or 3, more preferably 2.
- ammonium phosphate ester group V may be replaced by a glycerol derivative of the formula VB, VC or VD defined in our earlier publication no WO-A-93/01221.
- the zwitterionic monomer preferably has the formula VI
- B is a straight or branched alkanediyl, or alkanediyloxaalkanediyl or alkanediyl oligo (oxaalkanediyl) chain optionally containing one or more fluorine atoms up to and including perfluorinated chains or, if X or Y contains a terminal carbon atom bonded to B, a valence bond;
- X is the zwitterionic group
- Y is an ethylenically unsaturated polymerisable group selected from
- R is hydrogen or a C 1 -C 4 alkyl group
- R 11 is hydrogen or a C 1 -C 4 alkyl group or R 11 is —B—X where B and X are as defined above;
- R 12 is hydrogen or a C 1-4 alkyl group or BX where B and X are as defined above;
- A is —O— or —NR 11 ;
- K is a group —(CH 2 ) p OC(O)—, —(CH 2 ) p C(O)O—, —(CH 2 ) p OC(O)O—, —(CH 2 ) p NR 13 —, —(CH 2 ) p NR 13 C(O)—, —(CH) p C(O)NR 1 13 —, —(CHD) p NR 13 C(O)O—, —(CH 2 p OC(O)NR 13 —, —(CH 2 ) p NR 13 C(O)NR 13 — (in which the groups R 13 are the same or different), —(CH 2 ) p O—, —(CH 2 ) p SO 3 —, or, optionally in combination with B, a valence bond and p is from 1 to 12 and R 13 is hydrogen or a C 1 -C 4 alkyl group.
- Y is a group CH 2 ⁇ C(R)COA—, in which R is H or methyl, preferably methyl, and in which A is preferably O.
- B is preferably an alkanediyl group of 1 to 12, preferably 2 to 6 carbon atoms, most preferably group (CH 2 ) q in which q is 2 to 6.
- Each of the cationic and anionic monomers may be represented by the formula VII
- B 1 is selected from the same groups as B;
- Q is an ionic or ionisable group.
- Q may be a cationic group Q 1 or an anionic group Q 2 .
- a polycationic polymer will have permanently cationic pendant groups. These may be quaternary ammonium or phosphonium groups. In other embodiments, the cationic group may not be a permanent cation. It may be a weak or a strong base. For instance it may be selected so as to provide pH sensitivity whereby the degree of attraction between the two first polymers may be controlled by the pH.
- the anion may be the anion of a weak or strong acid, selected so as to be pH sensitive or insensitive within a predetermined pH range, as desired.
- a suitable cationic group Q 1 is preferably a group N + R 1 3 , P +l R 1 3 or S + R 1 2
- the groups R 1 are the same or different and are each hydrogen, C 1-4 -alkyl or aryl (preferably phenyl) or two of the groups R 1 together with the heteroatom to which they are attached from a saturated or unsaturated heterocyclic ring containing from 5 to 7 atoms.
- the cationic group is permanently cationic, that is each R 1 is other than hydrogen.
- the cationic group is N + R 1 3 in which each R 1 is C 1-4 -alkyl, preferably methyl.
- Suitable anionic groups Q 2 are carboxylate, carbonate, sulphonate, sulphate, phosphonate or phosphate.
- the anionic group is monovalent.
- a sulphonate group is particularly convenient.
- diallyl dialkyl ammonium halide for instance diallyl dimethyl ammonium chloride.
- Nonionic monomer included in either or both of the cationic and anionic polymer is selected so as to confer desired solubility, hydrophilicity or hydrophobicity properties, viscosity properties on the individual polymers and on the PIC.
- Hydrophobic groups may provide inter or intra molecular interactions with hydrophobic groups, or with substrates or biological compounds in contact with the PIC in use.
- a nonionic monomer has the general formula VIII
- R 14 is a nonionic organic group which is an optionally substituted C 1-24 -alkyl or -alkenyl group.
- Optional substituents in the alkyl or alkenyl group are hydroxyl groups, halogen atoms, alkoxy and oligo-alkoxy groups, in which the alkoxy groups have 1-6, preferably 2 or 3 carbon atoms, aryl groups, preferably optionally substituted phenyl groups (optional substituents in a phenyl group being hydroxyl groups, halogen atoms or alkyl groups), acyl groups, especially C 1-6 -alkanoyl groups, acyloxy groups, especially C 1-6 -alkanoyloxy groups or acylamino groups, especially C 1-6 -alkanoyl amino, in any of which alkanoyl and acyl groups there may be substituents selected from halogen atoms and hydroxyl groups.
- Preferred groups R 14 are C 1-24 unsubstit
- the liquid may be derived from, that is consist of, solvents from which the anionic and cationic polymers are presented in a method of forming the PIC by mixing two preformed solutions. Simce each ofthe polymers is preferably water-soluble, and since it may often be convenient for the PIC to be swollen in water, preferably both the anionic and cationic polymers are dissolved in an aqueous solvent.
- each ofthe solutions preferably contains polymer in amounts in the range 0.1 to 50% by weight, preferably in the range 1 to 50%, for instance in the range 10 to 25% by weight.
- the water-swellability of the PIC is such that the PIC will absorb deionised water in an amount of 10 to 1000% based on the weight of polymer, preferably in the range 50 to 500%.
- the polymer solutions are mixed in the method of the invention so as to allow intimate contact between the counterionically charged polymers. It is preferable that, after the solutions have been mixed, that the mixture is allowed to rest for a period to develop gel properties.
- the gel of the PIC swollen in a liquid may be used immediately without further processing. Alternatively it may be desirable to recover the PIC from the liquid vehicle and re-gel the PIC in an alternative solvent, or in the same type of solvent, optionally after rinsing in the same or other solvent, for instance to extract salts formed from counterions ofthe anionic and cationic pendant groups in the respective starting polymers (the microions).
- the PIC is generally water-insoluble, it may be possible to dissolve, redissolve or disperse the PIC in a non-aqueous solvent such as an alcohol or ether solvent, or in a solvent system such as is used in the new method of the invention.
- a solution of the PIC in such a solvent may be useful as a coating composition, for coating substrates to improve their biocompatibility.
- the method of the invention may suitably be carried out in situ to provide a gel product in a desired location, such as in contact with a biological liquid or with tissue.
- the PIC's of the present invention are believed to have desirable biocompatibility and are useful in environments where PIC's have previously been used such as in compositions to be used in contact with blood, for instance in embolising blood vessels.
- PIC's are in in situ coating of the internal surfaces of blood vessels, known as endoluminal gel-paving, as described in WO-A-9112846 and WO-A-9001969, filling of wound cavities, as fillers for various therapeutic and cosmetic purposes, e.g. for use following tumour excision, for use to improve muscle control, e.g. of sphincter muscles to control incontinence, as a supplement to synovial fluid, a filler for use in the treatment of patent ductus arteriosis, etc.
- the PIC's may be used in products in which a pharmaceutically active agent or a diagnostic agent is incorporated.
- the PIC may be a drug delivery depot from which pharmaceutically active ingredient may be delivered over time systemically or locally in a patient.
- a diagnostic agent may, for instance, be a radiopaque component, such as dispersed particulate radiopaque material (barium sulphate, for instance), or may be a solid device having a particular shape, such as a coil, filament, wire or thread of a metal.
- a radiopaque material may allow visualisation of the PIC in situ and the surrounding environment.
- FIG. 1 is a phase diagram for the formation of polyion complexes from systems based on Mpc x Bma y Tem z and Mpc x Bma y Spm z (see below for abbreviations);
- FIG. 2 is a generalised diagram for the formation of polyion complexes
- FIG. 3 is a phase diagram for the formation of polyion complexes from systems based on Mpc x Gma y Tem z and Mpc x Bma y Spm z .
- the polymers were developed using free radical solution polymerisation techniques following the standard method outlined below.
- 2-(methacryloyloxyethyl)-2′-(trimethyl-ammoniumethyl) phosphate, inner salt (Mpc) was prepared according to the method described previously WO-A-95/14702.
- Bma, Spm and Bma are all commercially available.
- a triple-necked round bottom flask (500 ml) was equipped with a Davis condenser, a nitrogen inlet and a thermometer.
- the condenser was topped with a calcium chloride guard tube, and a magnetic follower was added to the flask.
- the reaction system then purged using nitrogen gas.
- the solutions were then filtered under vacuum using a Buchner fimnel, into the reaction vessel.
- the solution was degassed using a constant flow of nitrogen for a period of twenty minutes, after which time the nitrogen flow rate was reduced and the temperature increased to suitable level dictated by the reaction solvent in use.
- the polymerisation was carried out under an atmosphere of nitrogen, and maintained at temperature for a period between 1640 hours.
- the solution was allowed to cool and the polymer purified by ultrafiltration to remove low molecular weight species.
- the polymer could be isolated by freeze drying for subsequent analysis.
- Table 1 summarises the preparative details for a selected range of polyion compounds and Table 2 the isolation details for those polymers.
- Table 3 provides some characterisation for the polymers in terms of 1H NMR. Elemental analysis was acceptable compared to theoretical values for most cases (within 10%,error as expected for polymers); table 4 however, summarises the key elemental data, concentrating on phosphorus:nitrogen and phosphorus:sulphur ratios in order to determine extent of Tem and Spm incorporation in the respective polycations and anions. This can subsequently be used to better define the final polymer composition versus the feed monomer ratios (as shown in table 1 to 3). The inherent viscosity of 20% w/v aqueous solutions of the polyions was obtained by rheometry, as an approximate indicator of molecular weight, and is reported in Table 5.
- Table 6 summarises some of the observations made upon mixing 20% w/v aqueous solutions of various polyions produced in Example 1 (the ratios are for the monomer in the polymerisation mixture rather than in the polymer by analysis).
- a solution of the PIC could then be used to produce reproducible coatings on PET that could be used for biological evaluation. Strips were subjected to a double antibody fibrinogen assay (Fg) and micro bicinchoninic acid protein assay ( ⁇ -BCA) in order to gain an appreciation of the extent of protein interaction with the materials. Table 8 summarises the results. Again the polyions are defined by reference to the ratios of monomers used.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Pyridine Compounds (AREA)
- Macromonomer-Based Addition Polymer (AREA)
Abstract
A polyion complex (PIC) is formed of an anionic soluble polymer formed from ethylenically unsaturated monomers including at least one anionic or monomer and a cationic soluble polymer formed from ethylenically unsaturated monomer including at least one cationic monomer, in which the monomers used to form at lest one of the polymers comprise a switterionic monomer and in which the monomers used to form at least one of the polymers include non-ionic monomer, preferably C1-24 alkyl(meth)acrylate, in which the overall ratio of anionic groups to cationic groups in the PIC is in the range 1.5:1 to 1:1.5, and in which the polymers are combined in ratios to provide a PIC in which there are units derived from zwitterionic monomer in an amount in the range 1 to 70 mole % based on total monomer derived units in the PIC and there are units derived from non-ionic monomer in an amount in the range 0 to 60 mole % based on total monomer derived units in the PIC. The PIC is preferably swollen in water and is a flowable gel The zitterionic monomer is preferably 2-(methacyloyloxyethyl)-2′-(trimethylammoniumethyl)phosphate inner salt.
Description
- The present invention relates to polyion complexes, that is intimate blends of overall cationic polymers and overall anionic polymers, at least one of which said polymers has pendant zwitterionic groups to provide improved biocompatibility.
- Physical gels are three-dimensional, disordered networks formed by associative forces that initiate noncovalent crosslinks. Mechanisms of interaction are numerous, including hydrogen bonding, hydrophobic interactions, crystalline segment formation and ionic association amongst others (Tanaka & Edwards,Macromolecules, 25, 1516, 1992).
- In contrast to chemical gels that have defined point crosslinks, physical gels have so-called junctions zones where linear segments of the polymer chain form ordered structures. The nature and number of these zones determine the differences between gels.
- It is well known in the literature that there are water-soluble polymers that contain complexing groups, whether neutral or charged, that can form gels by ionic association. This is most commonly achieved by the presence of sufficient inorganic metal salts under the appropriate conditions. The bonding chemistry between the metal ions is specific, each forming a gel with different polymers under specific conditions of pH, ionic strength and concentration of the polymer.
- Another method of obtaining a gel by complexation of relevance to this invention, is by the formation of an interpolymer complex. As its name suggests, this is a process by which two distinct polymer entities interact to form a complex. If complexation is achieved by the interaction of oppositely charged ionic groups within the two polymers, the system is termed a polyion or polyelectrolyte complex (Michaels,Indust. & Eng. Chemistry, 57 32, 1965). If the interaction is between a strongly acidic polyanion and a strongly basic polycation, coulombic forces at the polyion sites results in the release of a microanion and microcation (the counterions of the original polyelectroytes), which are then free to diffuse into the body ofthe solvent. The reaction will propagate rapidly from site to site, releasing the microions providing the entropy increase upon their liberation is not outweighed by the entropy decrease upon collapse and condensation ofthe polyion pair.
- The polyion complexes have the potential to be solubilised in ternary solvent systems consisting of water, a water-soluble organic solvent like acetone and a strongly ionised simple electrolyte such as NaBr. This allows fabrication into many forms including fibres, films and coatings. This, together with their reported inherent non-thrombogenic nature, has made these materials interesting as biomaterials (Ratner & Hoffman, ACS Symposium Series 71 ed. J. D. Andrade, ACS, Washington D.C., 1976, p1).
- The use of polyion complexes in medical applications has been suggested for many years. Indeed, Michaels made reference to the use of such complex solutions for potting or encapsulating aneurysms, commenting that the materials were reasonably well tolerated by the tissue. Ioplex 101 (a complex poly(triethyl-(3 & 4)-vinylphenylammonium bromide) and poly(sodium vinyl benzenesulphonate)) has been examined intensively for biomedical usage (Vogel el al.J. MacromoL Sci., Chem., 4, 675, 1970; Marshall et al., J. Biomed Mater. Res.,4, 357,1970; Bruck et al., Ann. N.Y. Acad Sci., 283 332, 1977). Analogues of this system have been studied to determine the effect of charge and structure on the complex and their behaviour towards blood platelets (Kataoka el al., Makromol. Chem., 179 1121, 1978 & 181, 1363, 1980) and have been used as encapsulating agents in the development of artificial liver support systems (Kataoka et al., Jinko Zoki (Artificial Organs), 8 296, 1979).
- Nakabayashi et al have previously described the use of polyion complexes of polymers having <zwitterionic pendant groups for the selective adhesion of platelets (J. Biomed. Mater. Res., 28(11), 1347, 1994 by Ishihara et al. Adv. Biomat. Biomed. Eng. Drug Delivery Syst. (1995) 227-228 by Ishihara, K. et al., and Japanese Patent JP-A-7-238124). Their invention claims specifically the use of a ternary polymer system consisting of 2-methacroyoyloxyethyl phosphorylcholine (MPC), butyl methacrylate (BMA) and sulfur propyl methacrylate (SPM) or trimethyl anmmonium propyl methacrylate (TPM). Further to this, they define the compositions in which the MPC:BMA molar ratio is between 2:98 - 50:50, and the ratio of these two components to the ionic monomer (SPM or TPM) is between 98:2-80:20. These systems seem to have been designed to produce coatings with weak ionic interactions that have favourable properties in terms of platelet binding and activation. The anionic and cationic polymers are water insoluble, alcohol soluble. The polyion complexes described in these references are tested as coatings on glass beads and one of the products is said to be under test for use to encapsulate activated charcoal used for an artificial liver support system. Coatings of the PIC's are produced by mixing preformed solutions at 10% solids concentrations of the terpolymers each in ethanol, dipping the substrate to be coated in the solution and allowing the alcohol to evaporate from the film of coating composition.
- JP-A-08-165491 (1996) describes complexes formed of a polymer having an overall cationic charge and which further includes pendant hydrophobic groups and pendant carboxybetaine groups, with an anionic surfactant such as α-olefin sulphonates and fatty acid soaps. The complexes are flexible solids and are for use with detergent components.
- JP-A-10-245325 (1998) describeshair setting compositions comprising a cationic polymer having pendant hydrophobic groups, and a polymer having pendant carboxybetaine groups and pendant hydrophobic groups.
- According to the invention there is provided a new method in which a solution of an anionic polymer having an overall anionic charge and a cationic polymer having an overall cationic charge together in a solvent system comprising a first solvent and an inorganic salt, in solution, is gelled by contact with water, whereby the ions of the inorganic salts become dissociated from the polymer and extracted from the gel formed by electrostatic attraction between polymer bound cationic groups and polymer bound anionic groups, and is characterised in that at least one of the cationic and anionic polymers comprises zwitterionic groups.
- The method of the invention thus involves a transformation of the polymer from being in a mobile solution or suspension form to being a gel. The method generally involves collapsing of the gel, that is the gel has a lower volume than the starting volume of the solution in the solvent system.
- In the method, the solvent system generally comprises an organic solvent. Preferably the organic solvent is water-miscible. Most preferably the solvent system comprises at least two solvents, in which the second solvent is water.
- Examples of suitable organic solvents for use in the solvent systems are alcohols, ethers, esters and, most preferably, ketones. Most preferably the solvent is a ketone such as acetone.
- For a solvent system comprising two solvents, these are generally used in a ratio in the range 5:1 to 1:5. Preferably the range of organic solvent water is in the range 2:1 to 1:5, preferably 1:1 to 1:4.
- The inorganic salts should be soluble in the solvent system. Where the solvent system contains water, therefore, the salt should be water-soluble, for instance at a concentration of at least 10% by weight. Preferably the salt is soluble in a concentration of at least 20% by weight.
- Preferably the salt comprises a single, preferably monovalent metal salt. Di- or higher valent metal salts may cause premature coagulation or gelation. Likewise the anion of the salt is preferably a sinly charged anion, preferably of a strong acid, most preferably other than an oxyanion although some oxyanions may be useful. Preferably the anion is a halide. The salt is preferably a halide of an alkali metal. The alkali metal is lithium, potassium, or, preferably, sodium. The halide is suitably chloride, bromide or iodide.
- The salt is preferably present in the solvent system in an amount of at least 2% by weight, preferably at least 5% by weight, for instance up to 20%/ by weight. Preferably the salt is present in an amount in the range 5 to 15% by weight.
- In the method of the invention, the polymer bound cationic and anionic groups may comprise charged atoms in the backbone of the molecule. Cationic groups formed in the backbone of the polymer may, for instance, be secondary, tertiary or quaternary ammonium groups. Preferably, however, the cationic and anionic groups ofthe polymers are pendant groups. Likewise the zwitterionic monomer is preferably a pendant group.
- The individual polymers used in the method of the invention are preferably water-soluble, for instance produce a clear solution at a concentration of at least 1%, more preferably at least 5%, by weight.
- The mixed solution of the two polymers in the solvent system may be generated by mixing together preformed solutions of the individual polymers in portions of the solvent system, or components thereof. It is generally preferred that all of the components are present in combination when the polymers first contact one another, in order to avoid premature gelling. Mixing procedures generally involve adequate stirring and temperatures which provide the desired solubility.
- The individual polymers may be of low or high molecular weight. Preferably the molecular weight is low enough for the solution of the individual monomer in a single solvent to be mobile and of low viscosity, to optimise handling. It is preferred that the inherent viscosity of the polymer solutions according to the test provided hereinafter is in the range 5 to 500 mPa.s, more preferably in the
range 10 to 300 mPa.s, for instance in therange 20 to 150 mPa.s. - In the method of the invention it is preferred that both of the polymers have zwitterionic groups, preferably zwitterionic pendant groups. It is preferred for the zwitterionic group to comprise a monovalent anion and monovalent cation. Where the zwitterion comprises an excess of anion over cation or vice versa, the zwitterionic group may finction as both polymer bound anion or cation, as the case may be, and zwitterion.
- In the method, it is preferred that approximately equivalent levels of anionic and cationic groups are present so that the anionic charges and cationic charges are balanced. It is preferred for the polymer mixture to have substantially no overall charge. It is believed that this characteristic optimises biocompatibility, especially haemocompatibility. The worked examples described below show that the gels have low protein adsorption properties.
- In the method of the present invention water is contacted with the solution of the mixed polymers in the solvent system by any suitable means. For instance the interface of a body of the solution with water may be provided at the surface of a coating on a substrate, or the solution may be restrained in a mould providing means for contacting the solution in the mould with water. Liquid excluded from the gel, upon collapse, for instance, may be removed by evaporation or by draining from the gel. The water may be contacted with the solution by spraying, flowing or dipping.
- Some of the PIC's formed by the new phase change, gelification procedure, are novel in themselves. Thus PIC's formed from combinations of certain selected polymers have not been disclosed in the prior art. It may be possible to make the PIC's by alternative processes, such as by depositing them from a mixed solvent system in which they are soluble, followed be evaporation of the solvent, that is using the general procedure described by Ishihara et al., op.cit.
- Preferred zwitterions, cations and anions and monomers from which polymers used in the method of the invention are described below.
- A new polyion complex according to the present invention is formed from a cationic polymer having an overall cationic charge and an anionic polymer having an overall anionic charge, in which the anionic polymer is obtainable by polymerising ethylenically unsaturated monomers comprising:
- a) 5 to 100 mole % anionic monomer having an anionic or anionisable group;
- b) 0 to 85 mole % zwitterionic monomer having a zwitterionic group; and
- c) 0 to 80 mole % nonionic monomer;
- and in which the cationic polymer is obtainable by polymerising ethylenically unsaturated monomers including
- d) 5 to 100 cationic monomer having a cationic or cationisable group;
- e) 0 to 85 mole % zwitterionic monomer having a pendant zwitterionic group; and
- f) 0 to 80 mole % non ionic monomer;
- in which the total units in the polyion complex derivable from nonionic monomer c and f is in the range 0 to 60 mole %, the total mole % of units in the PIC derivable from zwitterionic monomer is in the range 1 to 70 mole %, and the ratio of moles of anionic or anionisable groups in the anionic polymer to the moles of cationic or cationisable groups in the cationic polymer is in the range 1.5:1 to 1:1. 5.
- According to a fuirther aspect of the present invention a new polyion complex is formed from a cationic polymer having an overall cationic charge and an anionic polymer having an overall anionic charge, in which the anionic polymer is water soluble and is obtainable by polymerising monomers including
- a) 5 to 100 % anionic monomer having an anionic or anionisable group;
- b) 0 to 85 mole % zwitterionic monomer having pendant zwitterionic group; and
- c) 0 to 60 mole % non ionic monomer;
- and in which the cationic polymer is water soluble and is obtainable by polymerising ethylenically unsaturated monomers including
- d) 5 to 100 mole % cationic monomer having a cationic or cationisable group;
- e) 0 to 85 mole % zwitterionic monomer having a zwitterionic pendant group; and
- f) 0 to 60 mole % nonionic monomer;
- in which the total moles of units in the PIC derivable from zwitterionic monomers in the range 1 to 70 mole %, and in which the ratio of equivalents of anionic groups in anionic polymer to equivalents of cationic groups in cationic polymer is in the range 1.5:1 to 1:1.5.
- In all aspects of the invention, the total level of units derivable from nonionic monomer in the PIC is preferably at least 5 mole %.
- In all aspects of the invention, the anionic polymer preferably does not include units derivable from cationic monomer and the cationic polymer preferably does not include units derivable from anionic monomer.
- The components of the PIC, in terms of the cationic and anionic polymers and the monomers from which each polymer is made, are generally selected such that an aqueous gel of the novel PIC product of the novel process flows under imposition of the force rendering it capable of being pumped. For PIC's formed from cationic and anionic polymers having relatively high proportions of cationic and anionic groups, respectively, the desired properties are achievable by using relatively high proportions of zwitterionic monomer. For instance the total units derivable from zwitterionic monomer in the PIC is preferably at least 30 mole %, generally less than 50 mole %. Where the total moles of ionic monomer in the PIC is less than 30, for instance in the
range 10 to 30 mole %, then the level ofunits in the PIC derivable from zwitterionic monomer is preferably in the range 15 to 70 mole %. Where the total moles of ionic monomer in the PIC is in the range 5 to 10 mole %, then the level of units derivable from zwitterionic monomer in the PIC is preferably in therange 70 to 30 mole %. - The ratio of equivalents of anionic groups in anionic polymer to equivalents of cationic groups in cationic polymer (not including neutralised cation/anion pairs of a zwitterionic group) is preferably in the range 1.25:1 to 1:1.25, more preferably in the range 1.1:1 to 1:1. 1, preferably about 1:1. Preferably therefore the PIC have no overall charge.
- The PIC should generally be water-insoluble, but water-swellable. The PIC's may absorb more than their own weight of water, often more than twice their own weight for instance up to 10 times their own weight.
- The rheological properties of the PIC, for instance swollen by water, may be determined by using a variable torque oscillation test in a suitable rheometer. Such a device can determine the elasticity modulus and the viscous modulus. The present invention is directed in particular to PIC's which, when swollen in water, and subjected to the test as set out in the following paragraph have values of G′ (elasticity modulus) and G″W (viscous modulus) of G′ in the range 1 to 1000 and G″ in the range 5 to 1000. Generally the test is conducted when the gels are fully swollen in water.
- The viscoelastic properties are determined using a variable torque oscillation test (80 mN.m) using a TA instrument CSL-100 rheometer fitted with 6cm 2° cone at 37° C.
- The zwitterionic pendant group of the polymer used in the invention may have an overall charge, for instance by having a divalent centre of anionic charge and monovalent centre of cationic charge or vice-versa or by having two centres of cationic charge and one centre of anionic charge or vice-versa. Preferably, however, the zwitterion has no overall charge and most preferably has a centre of monovalent cationic charge and a centre of monovalent anionic charge.
- Preferably the centre of cationic charge in the zwitterionic group is permanent, that is it is preferably a quaternary ammonium or phosphonium or tertiary sulphonium group. Preferably the anion is permanent, that is it is substantially completely ionised at in vivo pH's, for instance at pH's in the range 5 to 8. It is preferably a phosphate, phosphonate, sulphate or sulphonate anion.
- The zwitterionic group may be a betaine group (ie in which the cation is closer to the backbone), for instance a sulpho-, carboxy- or phospho-betaine. A betaine group should have no overall charge and is preferably therefore a carboxy- or sulpho-betaine. If it is a phosphobetaine the phosphate terminal group must be a diester, i.e., be esterified with an alcohol. Such groups may be represented by the general formula I
- —X2—R2—N⊕(R3)2—R4—V⊖ I
- in which X2 is a valence bond, —O—, —S— or —NH—, preferably —O—;
- V is a carboxylate, sulphonate or phosphate diester(monovalently charged) anion;
- R2 is a valence bond (together with X2) or alkanedyl —C(O)alkanediyl— or —C(O)NHalkanediyl preferably alkanediyl and preferably containing from 1 to 6 carbon atoms in the alkanediyl chain;
- the groups R3 are the same or different and each is hydrogen or alkyl of 1 to 4 carbon atoms or the groups R3 together with the nitrogen to which they are attached form a heterocyclic ring of 5 to 7 atoms; and
- R4 is alkanediyl of 1 to 20, preferably 1 to 10, more preferably 1 to 6 carbon atoms.
-
- where the groups R5 are the same or different and each is hydrogen or C1-4 alkyl and n is from2to 4.
- Preferably the groups R5 are the same. It is also preferable that at least one ofthe groups R5 is methyl, and more preferable that the groups R5 are both methyl.
- Preferably n is 2 or 3, more preferably 3.
-
- in which X3 is a valence bond, —O—, —S— or —NH—, preferably —O—, R6 is a valence bond (optionally together with X3) or alkanediyl, —C(O)alkanediyl— or —C(O)NHalkanediyl, preferably alkanediyl and preferably containing from 1 to 6 carbon atoms; and
- the groups R7 are the same or different and each is hydrogen or alkyl of 1 to 4 carbon atoms, preferably methyl, or two of the groups R7, together with the nitrogen to which they are attached, form a heterocyclic ring of from 5 to 7 atoms, or the three group R7 together with the nitrogen atom to which they are attached form a fused ring structure containing from 5 to 7 atoms in each ring.
-
- in which the moieties X4 and X5, which are the same or different, are —O—, —S—, —NH— or a valence bond, preferably —O—, and
- W+ is a group comprising an anrnonium, phosphonium or sulphonium cationic group and a group linking the anionic and cationic moieties which is preferably a C1-12—alkylene group.
- Preferably W contains as cationic group an ammonium group, more preferably a quatemary ammomum group.
- The group W+ may for example be a group of formula
- —W1-N+R 8 3, —W1—P+R9 3, —W1—S+R9 2 or —W1—Het+ in which:
- W1 is alkanediyl of 1 or more, preferably 2-6, carbon atoms optionally containing one or more ethylenically unsaturated double or triple bonds, disubstituted-aryl, alkylene aryl, aryl alkylene, or alkylene aryl alkylene, disubstituted cycloalkyl, alkylene cycloalkyl cycloalkyl alkylene or alkylene cycloalkyl alkylene, which group W1 optionally contains one or more fluorine substituents and/or one or more functional groups; and
- either the groups R8 are the same or different and each is hydrogen or alkyl of 1 to 4 carbon atoms, preferably methyl, or aryl, such as phenyl, or two of the groups R8 together with the nitrogen atom to which they are attached form a heterocyclic ring containing from 5 to 7 atoms or the three groups R8 together with the nitrogen atom to which they are attached form a fused ring structure containing from 5 to 7 atoms in each ring, and optionally one or more of the groups R8 is substituted by a hydrophilic functional group, and
- the groups R9 are the same or different and each is Rs or a group OR8, where R8 is as defined above; or
- Het is an aromatic nitrogen-, phosphorus- or sulphur-, preferably nitrogen-, containing ring, for example pyridine.
- Preferably W1 is a straight-chain alkanediyl group, most preferably 1,2-thanediyl.
-
- where the groups R10 are the same or different and each is hydrogen or C1-4 alkyl, and m is from 1 to 4.
- Preferably the groups R10 are the same. It is also preferable that at least one of the groups R10 is methyl, and more preferable that the groups R10 are all methyl.
- Preferably m is 2 or 3, more preferably 2.
- Alternatively the ammonium phosphate ester group V may be replaced by a glycerol derivative of the formula VB, VC or VD defined in our earlier publication no WO-A-93/01221.
- The zwitterionic monomer preferably has the formula VI
- YBX VI
- wherein
- B is a straight or branched alkanediyl, or alkanediyloxaalkanediyl or alkanediyl oligo (oxaalkanediyl) chain optionally containing one or more fluorine atoms up to and including perfluorinated chains or, if X or Y contains a terminal carbon atom bonded to B, a valence bond;
- X is the zwitterionic group; and
-
-
- wherein:
- R is hydrogen or a C1-C4 alkyl group;
- R11 is hydrogen or a C1-C4 alkyl group or R11 is —B—X where B and X are as defined above; and
- R12 is hydrogen or a C1-4 alkyl group or BX where B and X are as defined above;
- A is —O— or —NR11;
- K is a group —(CH2)pOC(O)—, —(CH2)pC(O)O—, —(CH2)pOC(O)O—, —(CH2)pNR13—, —(CH2)pNR13C(O)—, —(CH)pC(O)NR1 13—, —(CHD)pNR13C(O)O—, —(CH2 pOC(O)NR13—, —(CH2)pNR13C(O)NR13— (in which the groups R13 are the same or different), —(CH2)pO—, —(CH2)pSO3 —, or, optionally in combination with B, a valence bond and p is from 1 to 12 and R13 is hydrogen or a C1-C4 alkyl group.
- Preferably Y is a group CH2═C(R)COA—, in which R is H or methyl, preferably methyl, and in which A is preferably O.
- B is preferably an alkanediyl group of 1 to 12, preferably 2 to 6 carbon atoms, most preferably group (CH2)q in which q is 2 to 6.
- Each of the cationic and anionic monomers may be represented by the formula VII
- Y1B1Q VII
- in which Y1 is selected from the same groups as Y
- B1 is selected from the same groups as B; and
- Q is an ionic or ionisable group. Q may be a cationic group Q1 or an anionic group Q2.
- In some embodiments of the present invention, a polycationic polymer will have permanently cationic pendant groups. These may be quaternary ammonium or phosphonium groups. In other embodiments, the cationic group may not be a permanent cation. It may be a weak or a strong base. For instance it may be selected so as to provide pH sensitivity whereby the degree of attraction between the two first polymers may be controlled by the pH.
- Likewise, the anion may be the anion of a weak or strong acid, selected so as to be pH sensitive or insensitive within a predetermined pH range, as desired.
- A suitable cationic group Q1 is preferably a group N+R1 3, P+l R 1 3 or S+R1 2
- in which the groups R1 are the same or different and are each hydrogen, C1-4-alkyl or aryl (preferably phenyl) or two of the groups R1 together with the heteroatom to which they are attached from a saturated or unsaturated heterocyclic ring containing from 5 to 7 atoms. Preferably the cationic group is permanently cationic, that is each R1 is other than hydrogen. Preferably the cationic group is N+R1 3 in which each R1 is C1-4-alkyl, preferably methyl.
- Suitable anionic groups Q2 are carboxylate, carbonate, sulphonate, sulphate, phosphonate or phosphate. Preferably the anionic group is monovalent. A sulphonate group is particularly convenient.
- Another suitable type of cationic monomer copolymerisable with ethylenically unsaturated monomers is diallyl dialkyl ammonium halide, for instance diallyl dimethyl ammonium chloride.
- Nonionic monomer included in either or both of the cationic and anionic polymer is selected so as to confer desired solubility, hydrophilicity or hydrophobicity properties, viscosity properties on the individual polymers and on the PIC. Hydrophobic groups may provide inter or intra molecular interactions with hydrophobic groups, or with substrates or biological compounds in contact with the PIC in use.
- Preferably a nonionic monomer has the general formula VIII
- Y2 R14 VIII
- in which Y2 is selected from the same groups as Y; and
- R14 is a nonionic organic group which is an optionally substituted C1-24-alkyl or -alkenyl group. Optional substituents in the alkyl or alkenyl group are hydroxyl groups, halogen atoms, alkoxy and oligo-alkoxy groups, in which the alkoxy groups have 1-6, preferably 2 or 3 carbon atoms, aryl groups, preferably optionally substituted phenyl groups (optional substituents in a phenyl group being hydroxyl groups, halogen atoms or alkyl groups), acyl groups, especially C1-6-alkanoyl groups, acyloxy groups, especially C1-6-alkanoyloxy groups or acylamino groups, especially C1-6-alkanoyl amino, in any of which alkanoyl and acyl groups there may be substituents selected from halogen atoms and hydroxyl groups. Preferred groups R14 are C1-24 unsubstituted alkyl, more preferably. C4-18 alky.
- Where the PIC is used as a gel swollen with a liquid, the liquid may be derived from, that is consist of, solvents from which the anionic and cationic polymers are presented in a method of forming the PIC by mixing two preformed solutions. Simce each ofthe polymers is preferably water-soluble, and since it may often be convenient for the PIC to be swollen in water, preferably both the anionic and cationic polymers are dissolved in an aqueous solvent.
- In the method of the invention by admixing two preformed solutions, each ofthe solutions preferably contains polymer in amounts in the range 0.1 to 50% by weight, preferably in the range 1 to 50%, for instance in the
range 10 to 25% by weight. - Preferably the water-swellability of the PIC is such that the PIC will absorb deionised water in an amount of 10 to 1000% based on the weight of polymer, preferably in the
range 50 to 500%. - The polymer solutions are mixed in the method of the invention so as to allow intimate contact between the counterionically charged polymers. It is preferable that, after the solutions have been mixed, that the mixture is allowed to rest for a period to develop gel properties.
- The gel of the PIC swollen in a liquid may be used immediately without further processing. Alternatively it may be desirable to recover the PIC from the liquid vehicle and re-gel the PIC in an alternative solvent, or in the same type of solvent, optionally after rinsing in the same or other solvent, for instance to extract salts formed from counterions ofthe anionic and cationic pendant groups in the respective starting polymers (the microions).
- Whilst the PIC is generally water-insoluble, it may be possible to dissolve, redissolve or disperse the PIC in a non-aqueous solvent such as an alcohol or ether solvent, or in a solvent system such as is used in the new method of the invention. A solution of the PIC in such a solvent may be useful as a coating composition, for coating substrates to improve their biocompatibility.
- The method of the invention may suitably be carried out in situ to provide a gel product in a desired location, such as in contact with a biological liquid or with tissue.
- The PIC's of the present invention are believed to have desirable biocompatibility and are useful in environments where PIC's have previously been used such as in compositions to be used in contact with blood, for instance in embolising blood vessels.
- Other potential uses of the PIC's are in in situ coating of the internal surfaces of blood vessels, known as endoluminal gel-paving, as described in WO-A-9112846 and WO-A-9001969, filling of wound cavities, as fillers for various therapeutic and cosmetic purposes, e.g. for use following tumour excision, for use to improve muscle control, e.g. of sphincter muscles to control incontinence, as a supplement to synovial fluid, a filler for use in the treatment of patent ductus arteriosis, etc.
- The PIC's may be used in products in which a pharmaceutically active agent or a diagnostic agent is incorporated. For instance the PIC may be a drug delivery depot from which pharmaceutically active ingredient may be delivered over time systemically or locally in a patient. A diagnostic agent may, for instance, be a radiopaque component, such as dispersed particulate radiopaque material (barium sulphate, for instance), or may be a solid device having a particular shape, such as a coil, filament, wire or thread of a metal. A radiopaque material may allow visualisation of the PIC in situ and the surrounding environment.
- In the drawings
- FIG. 1 is a phase diagram for the formation of polyion complexes from systems based on MpcxBmayTemz and MpcxBmaySpmz (see below for abbreviations);
- FIG. 2 is a generalised diagram for the formation of polyion complexes; and
- FIG. 3 is a phase diagram for the formation of polyion complexes from systems based on MpcxGmayTemz and MpcxBmaySpmz.
- The invention is illustrated further in the accompanying examples. In these examples, the following standard methods are used:
- Inherent Viscosity
- 20% w/v solutions were made of each polymer using deionised water. The solution was subjected to a flow test (shear rate 1-1000 so−1) using a TA Instruments CSL2-100 Rheometer fitted with a 6 cm 2° cone at a temperature of 37° C. From the 3 0 resulting viscosity vs. shear rate trace, the viscosity (Pa.s) ofthe solution was determined by taking the value at 200 s−1.
- Fibrinogen Adsorption
- This test is carried out substantially as described in WO-A-93/01221.
- Bicinchoninic Acid Protein Assay
- Assessment of protein adsorption was carried out using the Micro-Bicinchoninic Acid (m-BCA) Protein Assay (Pierce & Warriner kit), which relies on the colourimetric detection of a Cu(I) complex with BCA produced upon protein reduction of Cu(H) to Cu(I). Coated and uncoated PET strips were prepared as described for the immunoassay, except that in this case they were cut in half and assayed as two 9×15 mm strips. Samples were incubated in 4 ml of 0.5 mgml−1 of fibrinogen solution for 10 minutes at room temperature. Sample blanks of uncoated PET strips were incubated in 4 ml of PBS in the same manner. Both samples and blanks were washed in a DiaCent 2000 cell washer and then transferred to clean tubes and incubated with 100 μg 1 PBS and 1 ml m-BCA working reagent at 60° C. A Bovine Serum Albumin (BSA) standard curve was constructed so as to give the required amount of protein in 100 μl solution. Standards were incubated with lml of working reagent as above. The absorbance of a 300 μl aliquot of the sample was measured in a microplate reader at 562 nm.
- Abbreviations Used:
Monomer Code Chemical Name Mpc Methacryloxyethyl phosphorylcholine (2- methacryloyloxyethyl-2′-trimethylammoniumethyl phosphate inner salt) Bma Butyl methacrylate (hydrophobic diluent) Tem 2-trimethylammonium ethyl methacrylate chloride salt Spm 3-methacryloyloxypropylsulphonate potassium salt EtOH ethanol TFE 2,2,2-trifluoroethanol THF tetrahydrofuran MeOH methanol DI Water deionised water DCM dichloromethane PET polyethyleneterephthalate PBS phosphate buffered saline - The polymers were developed using free radical solution polymerisation techniques following the standard method outlined below. 2-(methacryloyloxyethyl)-2′-(trimethyl-ammoniumethyl) phosphate, inner salt (Mpc) was prepared according to the method described previously WO-A-95/14702. Bma, Spm and Bma are all commercially available.
- A triple-necked round bottom flask (500 ml) was equipped with a Davis condenser, a nitrogen inlet and a thermometer. The condenser was topped with a calcium chloride guard tube, and a magnetic follower was added to the flask. The reaction system then purged using nitrogen gas.
- The required amount of Mpc was weighed and then stirred in a suitable reaction solvent until dissolved. To this was added the appropriate amounts of the other comonomers (ionic monomer and hydrophobic diluent if required). The initiator type and level was chosen depending upon the reaction solvent employed.
- The solutions were then filtered under vacuum using a Buchner fimnel, into the reaction vessel. The solution was degassed using a constant flow of nitrogen for a period of twenty minutes, after which time the nitrogen flow rate was reduced and the temperature increased to suitable level dictated by the reaction solvent in use. The polymerisation was carried out under an atmosphere of nitrogen, and maintained at temperature for a period between 1640 hours.
- When the polymerisation had finished the heat source was removed and the solution was allowed to cool to room temperature. In the case where a volatile reaction solvent or solvent mixture had been used, the solvent was removed using rotary evaporation techniques until the point at which the polymer began to foam. This foam was then further redissolved in a suitable solvent/non-solvent combination (typically 9:1 DCM:MeOH) and precipitated by dropwise addition into a non solvent, typically acetone (1000 ml) with constant stirring. The precipitate was then collected using vacuum filtration under a blanket of nitrogen and dried at 50° C. in vacuo for 16 hours.
- In the case where water was used as the reaction solvent, the solution was allowed to cool and the polymer purified by ultrafiltration to remove low molecular weight species. The polymer could be isolated by freeze drying for subsequent analysis.
- Once isolated, the individual polymers were subjected to NMR and elemental analysis to confirm the structure.
- Table 1 summarises the preparative details for a selected range of polyion compounds and Table 2 the isolation details for those polymers. Table 3 provides some characterisation for the polymers in terms of 1H NMR. Elemental analysis was acceptable compared to theoretical values for most cases (within 10%,error as expected for polymers); table 4 however, summarises the key elemental data, concentrating on phosphorus:nitrogen and phosphorus:sulphur ratios in order to determine extent of Tem and Spm incorporation in the respective polycations and anions. This can subsequently be used to better define the final polymer composition versus the feed monomer ratios (as shown in table 1 to 3). The inherent viscosity of 20% w/v aqueous solutions of the polyions was obtained by rheometry, as an approximate indicator of molecular weight, and is reported in Table 5.
- Table 6 summarises some of the observations made upon mixing 20% w/v aqueous solutions of various polyions produced in Example 1 (the ratios are for the monomer in the polymerisation mixture rather than in the polymer by analysis).
- 0.5 g of each polymer was completely dissolved in 2.5ml of deionised water to yield a clear solution. One solution of each of the pairs described was poured into the other and then mixed thoroughly with a spatula. In some instances, such as for the poly(Tem)/(Spm) pair, the gelation was almost instantaneous, forming a thick, swollen mass that incorporated all of the water from the system. If this was allowed to stand for a while, the gel could be seen to contract slightly, expelling some of the water from the matrix. It should be noted at this stage, that gels were mixed on an equivalent weight basis rather than using molar proportions (of monomer feed or groups in polymer as analysed).
- By talking the observations made in table 6 and plotting them in terms of a ternary phase diagram, it can be seen that there are trends visible (FIG. 1). In polymer systems in which the hydrophobic component is in high, the resulting polymers are water-insoluble and so cannot form a PIC from aqueous solution (although this may still be possible from other solvent systems). In systems where the PC component is high, both the individual polymers and the resulting PIC remain water-soluble. When the correct balance of ionic/hydrophilic/hydrophobic is obtained, a gel is formed as the polyions complex. This gel tends to be ‘stiffer’ when the hydrophilicity is reduced and when the ionic content is higher.
- Thus, a generalisation can be made for the formation of PICs in this type of system (FIG. 2). The application in mind will determine what type of PIC will be required. For instance, if one requires the formation of a gel for filling an aneurysm, the properties required from that gel will be such that it remains in place once formed; henceforth, if its tendency is to flow, it will not be suitable.
- When considering the ability of a mixture of two polyion solutions to form a gel as described in FIG. 2, it is useful to be able to quantify the observations made. In this instance, 20% (w/v) solutions of the individual polymers were made, mixed together and allowed to settle overnight. The resulting PICs were subected to a variable torque is oscillation test (10-100 mN.m) using a TA Instruments CSL2-100 rheometer fitted with 6 cm 2° cone at 37° C. From this, two parameters could be measured, namely G′ the elasticity modulus and G″ the viscous modulus. Table 7 summarises the measurements of these parameters for a variety of PIC mixtures, taken at 80 nN.m. The polyions are defined by reference to the monomer ratios used rather than from analysis ofionic groups in the polymer.
- Clearly, there a large spread in viscoelastic properties between the different PICs formed. The values are in agreement with the observations expressed in table 6 and reinforce FIGS. 1 & 2. Where values of G′ and G″ are low, little gelation has occurred when solutions have been mixed. Where these values are higher (ca.>10 Pa), a firm gel of has formed. When the value of G″ exceeds that of G′, the material has more viscous properties than elastic and it will tend to flow under applied force rather than act elastically. Where G′ is greater than G″ the opposite is true indicating a more elastic material with a propensity to withstand applied force. This is a useful measure of a materials' potential behaviour in a particular application. For instance, if an aneurysm-filling material is considered, it would be desirable to obtain a gel that will not wash out of the void under the influence of blood flow.
- A solubility study was performed on PC-PICs. They were found to be soluble in ternary solvent mixtures of water, ethanol and NaCl. The results are shown in the ternary phase diagram FIG. 3.
- A solution of the PIC could then be used to produce reproducible coatings on PET that could be used for biological evaluation. Strips were subjected to a double antibody fibrinogen assay (Fg) and micro bicinchoninic acid protein assay (μ-BCA) in order to gain an appreciation of the extent of protein interaction with the materials. Table 8 summarises the results. Again the polyions are defined by reference to the ratios of monomers used.
- From the data it can be seen that coatings of polyion complexes exhibit a lower degree of protein adsorption than the PET control strip. The comparison PIC made from mixing the homopolymers of Tem and Spm (5.3) is less effective at lowering the protein adsorption than those PIC's that contain Mpc. This is consistent with the view that Mpc improves the ‘biocompatibility’ of surfaces.
TABLE 1 Preparative Details for a Series of Polyions Reaction Reaction Initiator [Initiator] Scale Solids Polymer Solvent Time (mins) Temp (° C.) Type (%) (g) (%) MpcTem D.I. Water 24 80 APS 1 30 15 MpcSpm D.I. Water 24 80 APS 1 30 15 MpcBmaTem EtOH 24 70 AIBN 1 30 15 MpcBmaSpm EtOH 24 70 AIBN 1 30 15 Mpc40Bma40Tem20 THF/EtOH 18 70 AIBN 1 25 12.5 Mpc40Bma40Spm20 TFE 24 70 AIBN 1 25 12.5 Mpc15Bma35Tem50 EtOH 18 70 AIBN 1 25 12.5 Mpc15Bma35Spm50 EtOH 18 70 AIBN 1 25 12.5 MpcTem2 EtOH 24 60 AIBN 0.2 15 15 BmaSpm TFE 40 60 AIBN 0.4 30 12.5 Mpc15Tem85 D.I. Water 24 80 APS 1 25 12.5 Mpc13Spm85 D.I. Water 24 80 APS 1 25 12.5 Poly(Tem) D.I. Water 24 86 APS 1 25 12.5 Poly(Spm) D.I. Water 24 86 APS 1 25 12.5 -
TABLE 2 Isolation Details for a Series of Polyions Redissolution Precipitation Yield Yield Polymer Solvents Solvent (g) (%) Appearance Comments MpcTem — — 15.8 53 Fine, white powder Isolated by freeze-drying MpcSpm — — 27 90 Fine, white powder Isolated by freeze-drying MpcBmaTem 120 ml DCM/5 ml MeOH 780 ml Acetone 22.6 75 Fine, white powder MpcBmaSpm 120 ml DCM/5 ml MeOH 780 ml Acetone 16.9 56 Grey-white powder Mpc40Bma40Tem20 — 200 ml Acetone 13.8 55 Fine, white powder Mpc40Bma40Spm20 140 ml DCM/80 ml TFE 1.21 Acetone 17.3 69 Fine, white powder Mpc15Bma35Tem50 120 ml DCM/5 ml MeOH 780 ml Acetone 16.3 65 Lumpy white solid Mpc15Bma35Spm50 120 ml DCM/5 ml MeOH 780 ml Acetone 6.6 27 Lumpy white solid Difficult to isolate (low Mw?) MpcTem2 48 ml DCM/4 ml MeOH 500 ml Acetone 13.5 95 White solid BmaSpm 50 ml DCM/20 ml TFE 1.51 Acetone 26.8 89 Stringy solid Mpc15Tem85 — — ˜22.5 90 White solid Estimated yield by drying Mpc15Spm85 — — ˜22.5 90 White solid down a sample of solution Poly(Tem) — — ˜22.5 90 White solid Estimated yield by drying Poly(Spm) — — ˜22.5 90 White solid down a sample of solution -
TABLE 3 Summary of 1H NMR Data for a Series of Polyions. Polyion Solvent Description (Peak Positions) Comments Poly(Spm) D2O 0.9-1.1 (3 peaks, b); 1.95 (b); 2.15(s); 3.0 (triplet, —CH 2—S—); 4.15(b) As expected for structure Poly(Tem) D2O 0.9-1.2 (3 peaks, b); 2.05 (b); 3.3 (s, N+(CH 3)3); 4.85 (m); 4.5 (b) As expected for structure Mpc15Spm85 D2O 0.8-1.2 (2 peaks, b); 1.9 (b); 2.15 (s); 3.0 (triplet, —CH 2—S—); 3.3 (s, Integration of (N+(Me)3) vs. N+(CH 3)3); 3.7; 4.1-4.3 (2 peaks, b) —CH 2—S gives expected formula Mpc15Tem85 CD3OD 0.9-1.3 (3 peaks, b); 2.0 (b); 3.26 + 3.31 (overlapping, N+(Me)3 from Mpc Cannot integrate Mpc vs. Tem, peaks and Tem); 3.7-4.7 (6 peaks, overlapping, b) to close. MpcBmaSpm CD3OD 0.8-1.3 (3 peaks, b); 1.45 (—CH 2—CH3); 1.65 (—O—CH2—CH 2—); Integration of Mpc vs. Spm and 1.95; 2.15; 2.9 (triplet, —CH 2—S—); 3.3 (s, N+(CH 3)3); 3.7; elemental analysis suggests more like 3.9-4.4 (3 peaks, b) ˜Mpc25Bma33Spm40. Monomer contamination observed. MpcBmaTem CD3OD 0.9-1.2 (2 peaks, b); 1.45 (—CH 2—CH3); 1.65 (—O—CH2—CH 2—); Cannot integrate Mpc vs. Tem, peaks 1.95 (b); 3.3 + 3.32 (overlapping, N+(Me)3 from Mpc and Tem); to close. 3.7-4.7 (8 peaks overlapping, b) MpcSpm D2O 0.9-1.1 (2 peaks, b); 1.9-2.2 (2 peaks, b); 2.95 (vague triplet, Integration shows 50:50 Mpc:Spm as —CH 2—S—); 3.3 (s, N+(CH 3)3); 3.7; 4.1-4.4 (3 peaks, b) expected. MpcTem D2O 0.9-1.3 (2 peaks, b); 2.2 (b); 3.3 + 3.33 (overlapping, N+(Me)3 from Mpc Cannot integrate Mpc vs. Tem, peaks and Tem); 3.7; 3.9, 4.1-4.6 (3 peaks, b) to close. BmaSpm DMSO 0.7-1.0 (2 peaks, b); 1.35 (—CH 2—CH3); 1.55 (—O—CH2—CH 2—); Integration not possible as residual 1.85; 2.5 (—CH 2—S— is masked by DMSO); 3.9 (b) undeuterated DMSO masks Spm. MpcTem2 CD3OD 1.0-1,3 (2 peaks, b); 2.15 (b); 3.36 + 3.44 33 (overlapping, N+(Me)3, from Cannot integrate Mpc vs. Tem, peaks Mpc and Tem); 3.8-4.7 (7 peaks overlapping, b) to close. Mpc40Bma40Spm40 CD3OD 0.8-1.1 (3 peaks, b); 1.35 (—CH 2—CH3); 1.55 (—O—CH2—CH 2—); Integration yields formula as expected. 1.8 (b); 2.05 (b); 2.8 95 (triplet,—CH2—S—); 3.24 (s, N+(CH 3)3); 3.7; 3.9-4.3 (4 peaks, b), 4.6 Mpc40 Bma40Tem40 CD3OD 0.8-1.2 (2 peaks, b); 1.35 (—CH 2—CH3); 1.55 (—O—CH2—CH 2—); Cannot integrate Mpc vs. Tem, peaks 2.1 (b); 3.24 + 3.28 (overlapping, N+(Me)3 from Mpc and Tem); 3.6-4.7 to close. (7 peaks overlapping, b) -
TABLE 4 Selected P:N & P:S Ratios for the Confirmation of Polymer Formula (where applicable) Italics highlight cases where actual results significantly differ from those of the feed ratio. Polycation % % Theoretical Actual (molar feed ratio) Mpc Tem Phosphorus Nitrogen P:N P:N % Mpc % Tem MpcTem 50 50 4.8 4.9 0.904 1.021 39 56.5 MpcBmaTem 33.3 33.3 4.28 3.9 0.904 0.911 29.7 33.6 Mpc40Bma40Tem20 40 20 4.28 1.84 0.678 0.43 30 12.7 Mpc15Bma35Tem50 15 50 2.17 3.91 1.957 1.802 13.9 46 MpcTem2 33.3 66.7 3.2 5.05 1.356 1.578 24.4 77.5 Mpc15Tem85 15 85 1.7 5.31 3.019 3.124 12.1 87.9 Polyanion % % Theoretical Actual (molar feed ratio) Mpc Spm Phosphorus Sulphur P:S P:S % Mpc % Spm MpcTem 50 50 4.6 5.7 1.035 1.239 40.2 59.9 MpcBmaSpm 33.3 33.3 3.19 4.46 1.033 1.398 23.5 45.1 Mpc15Bma40Spm20 40 20 4.45 2.59 0.516 0.582 32.3 22.6 Mpc15Bma35Spm50 15 50 1.98 6.61 3.444 3.338 13.9 48.5 Mpc15Spm85 15 85 1.75 10.5 5.869 6 14.3 86.9 -
TABLE 5 Polymer Feed and Final Formulas Based on NMR and Elemental Data Presented in TABLES 4 & 5. Where fee ratios differs significantly from final ratio, the formula is shown in italics Inherent Viscosities obtained by Rheometry on 20% w/v Aqueous Solutions of the Polyions. Suggested Final Polymer Inherent Monomer Feed Formula Formula Viscosity (mPa · s) Poly(Tem) Poly(Tem) 40 MpcTem MpcTem 8.5 MpcBmaTem MpcBmaTem 10 Mpc40Bma40Tem20 Mpc 30Bma55Tem15 18 Mpc15Bma35Tem50 Mpc15Bma35Tem50 14 MpcTem2 MpcTem3 42 Mpc15Tem85 Mpc15Tem85 71 Poly(Spm) Poly(Spm) 300 MpcSpm MpcSpm 130 MpcBmaSpm Mpc 25Bma35Spm40 11 Mpc40Bma40Spm20 Mpc40Bma40Spm20 6 Mpc15Bma35Spm50 Mpc15Bma35Spm50 10 BmaSpm BmaSpm 14 Mpc15Spm85 Mpc15Spm85 250 -
TABLE 6 Some Observations Made upon Mixing Aqueous Solutions of Polyions. Polycation Polyanion Gel Formed? Appearance Comments MpcTem MpcSpm No Viscous liquid Mpc15Tem85 Mpc15Spm85 Yes Thick gel Opaque MpcTem SpmBma Yes Flowing gel Opaque MpcTem2 SpmBma Yes Thick gel Opaque, expels water MpcBmaTem MpcBmaSpm Yes Flowing gel Clear Mpc15Bma35Tem50 Mpc15Bma35Spm50 Yes Gel Clear Mpc40Bma40Tem20 Mpc40Bma40Spm20 Yes Flowing gel Opaque MpcBmaTem MpcSpm No Viscous liquid MpcTem MpcBmaSpm No Viscous liquid Mpc20Bma60Tem20 Mpc20Bma60Spm20 — — Polymers water-insoluble Poly(Tem) Poly(Spm) Yes Very thick gel Opaque, expels water -
TABLE 7 Viscoelastic Properties of Selected PIC gels Polycation Polyanion G′ (Pa) G″ (Pa) MpcTem BmaSpm 3.25 30 MpcTem BmaSpm 600 800 MpcTem MpcSpm 0.15 3.5 MpcTem MpcBmaSpm 0.025 0.48 MpcBmaTem MpcSpm 0.3 4 MpcBmaTem MpcBmaSpm 50 45 Mpc15Bma35Tem50 Mpc15Bma35Spm50 400 150 Mpc15Tem85 Mpc15Spm85 1500 1000 Mpc40Bma40Tem20 Mpc40Bma40Spm20 85 125 Poly(Tem) Poly(Spm) 9000 4500 -
TABLE 8 Estimation of Adsorbed Protein for PIC Coatings Using Fibrinogen (Fg) and bicinchoniic acid (μ-BCA) Assays (Uncoated PET strip control) Bioevaluation % Reduction of No Polyion Complex Pair Test Method Adsorbed Protein 5.1 MpcBmaTem + MpcBmaSpm Fg (n = 7) 77.8 5.2 Mpc15Bma35Tem50 + MPC15Bma35Spm50 Fg (n = 7) 77.7 5.3 Poly(Tem) + Poly(Spm) Fg (n = 7) 47.1 5.1 MpcBmaTem + MpcBmaSpm μ-BCA (n = 5) 82.4 5.2 Mpc15Bma35Tem50 + Mpc15Bma35Spm50 μ-BCA (n = 4) 61.8 5.3 Poly(Tem) + Poly(Spm) μ-BCA (n = 3) 33.7
Claims (28)
1. A polyion complex formed from a cationic polymer having an overall cationic charge and an anionic polymer having an overall anionic charge, in which the anionic polymer is obtainable by polymerising ethylenically unsaturated monomers including:
a) 5 to 100 mole % anionic monomer having an anionic or anionisable group;
b) 0 to 85 mole % zwitterionic monomer having a zwitterionic group; and
c) 0 to 80 mole % nonionic monomer;
and in which the cationic polymier is obtainable by polymerising ethylenically unsaturated monomers including
d) 5 to 100 cationic monomer having a cationic or cationisable group;
e) 0 to 85 mole % zwitterionic monomer having a pendant zwitterionic group; and
f) 0 to 80 mole % non ionic monomer;
in which the total units in the polyion complex derivable from nonionic monomer c and f is in the range 0 to 60 mole %, the total mole % of units in the polyion complex derivable from zwitterionic monomer is in the range 1 to 70 mole %, and the ratio of moles of excess anionic or anionisable groups in the anionic polymer to the moles of excess cationic or cationisable groups in the cationic polymer is in the range 1.5:1 to 1:1.5.
2. A polyion complex formed from a cationic polymer having an overall cationic charge and an anionic polymer having an overall anionic charge, in which the anionic polymer is water soluble and is obtainable by polymerising monomers including
a) 5 to 100% anionic monomer having an anionic or anionisable group; and
b) 0 to 85 mole % zwitterionic monomer having pendant zwitterionic group;
c) 0 to 60 mole % non ionic monomer;
and in which the cationic polymer is water soluble and is obtainable by polymerising ethylenically unsaturated monomers including
d) 5 to 100 mole % cationic monomer having a cationic or cationisable group;
e) 0 to 85 mole % zwitterionic monomer having a zwitterionic pendant group;
f) 0 to 60 mole % nonionic monomer; and
in which the total moles of units in the polyion complex derivable from zwitterionic monomers in the range 1 to 70 mole %, and in which the ratio of total moles anionic groups in excess of cationic groups in anionic polymer to total moles cationic groups in excess of anionic groups of cationic polymer is in the range 1.5:1 to 1:1.5.
3. A polyion complex according to claim 1 or claim 2 , in which the total of units derivable from nonionic monomer in the polyion complex is preferably at least 5 mole %.
4. A polyion complex according to any preceding claim in which the anionic polymer is formed from monomers substantially free of cationic monomer and the cationic polymer is formed of monomers substantially free of anionic monomer.
5. A polyion complex according to any preceding claim in which the ratio of total moles of anionic monomer used to form anionic polymer to total moles of cationic monomer used to form the cationic polymer is in the range 1.25:1 to 1:1.25, preferably in the range 1.1:1 to 1:1.1, preferably about 1:1.
6. A polyion complex according to any preceding claim which is water-insoluble and water-swellable.
7. A polyion complex according to any preceding claim in which the zwitterionic monomer preferably has the formula VI
YBX VI
wherein
B is a straight or branched alkanediyl or alkanediyloxaalkanediyl or alkanediyloligo(oxaalkanediyl) chain optionally containing one or more fluorine atoms up to and including perfluorinated chains or, if X or Y contains a terminal carbon atom bonded to B, a valence bond;
X is the zwitterionic group; and
Y is an ethylenically unsaturated polymerisable group selected from
CH2═C(R)—CH2—O—, CH2═C(R)—CH2OC(O)—, CH2═C(R)OC(O)—, CH2═C(R)—O—, CH2═C(R)CH2OC(O)N(R11)—, R12OCCR═CRC(O)—O—, RCH═CHC(O)O—, RCH═C(COOR12)CH2—C(O)—O—,
wherein:
R is hydrogen or a C1-4 alkyl group;
R11 is hydrogen or a C1-4 alkyl group or R11 is —B—X where B and X are as defined above; and
R12 is hydrogen or a C1-4 alkyl group or BX where B and X are as defined above;
A is —O— or —NR11—;
K is a group —(CH2)pOC(O)—, —(CH2)pC(O)O —, —(CH2)pOC(O)O—, —(CH2)pNR13—, —(CH)pNR13C(O)—, —(CH)pC(O)NR13—, —(CH2)pNR13C(O)O—, —(CH2)pOC(O)NR13—, —(CH)pNR13C(O)NR13— (in which the groups R13 are the sarne or different), —(CH)pO—, —(CH)pSO3—, or, optionally in combination with B, a valence bond and p is from 1 to 12 and R13 is hydrogen or a C1-4 alkyl group.
8. A polyion complex according to claim 7 in which the zwitterion has the formula IV
in which the moieties X4 and X5, which are the same or different, are —O—, —S—, —NH— or a valence bond, preferably —O—, and
W+ is a group comprising an ammonium, phosphonium or sulphonium cationic group and a group linking the anionic and cationic moieties which is preferably a C1-12-alkanediyl group.
9. A polyion complex according to claim 8 in which W+ is a group of fonnula —W1—N+R8 3, —W1—P+R9 3, —W1—S+R9 2 or —W1—Het+ in which:
W1 is alkanediyl of 1 or more, preferably 2-6 carbon atoms optionally containing one or more ethylenically unsaturated double or triple bonds, disubstituted-aryl, alkylene aryl, aryl alkylene, or alkylene aryl alkylene, disubstituted cycloalkyl, alkylene cycloalkyl, cycloalkyl alkylene or alkylene cycloalkyl alkylene, which group W1 optionally contains one or more fluorine substituents and/or one or more functional groups; and
either the groups R8 are the same or different and each is hydrogen or alkyl of 1 to 4 carbon atoms, preferably methyl, or aryl, such as phenyl or two of the groups R8 together with the nitrogen atom to which they are attached form a heterocyclic ring containing from 5 to 7 atoms or the three groups R8 together with the nitrogen atom to which they are attached form a fused ring structure containing from 5 to 7 atoms in each ring, and optionally one or more of the groups R8 is substituted by a hydrophilic functional group, and
the groups R9 are the same or different and each is R8 or a group OR8, where R8 is as defined above; or
Het is an aromatic nitrogen-, phosphorus- or sulphur-, preferably nitrogen-, containing ring, for example pyridine.
11. A polyion complex according to any preceding claim in which the anionic monomer and cationic monomer each have the formula VII
Y1B1Q VII
in which Y1 is an ethylenically unsaturated polymerisable group selected from
CH2═C(R15)—CH2—O—, CH2═C(R15)—CH2 OC(O)—, CH2═C(R15)OC(O)—, CH2═C(R15—, CH2—(R15)CH2OC(O)N(R15)—, R17OOCCR15═CR15C(O—O—, R15CH═CHC(O)O—, R15CH═C(COOR17)CH2—C(O)—O—,
wherein:
R15 is hydrogen or a C1-4 alkyl group;
is R16 is hydrogen or a C1-4 alkyl group or R16 is B1Q where B1 and Q are as defined below;
R17 is hydrogen or a C1-4 alkyl group or B1Q where B1 and Q are as defined below;
A1 is —O— or —NR16—;
K1 is a group —(CH2)rOC(O)—, —(CH2)rC(O)O—, —(CH2)rOC(O)O—, —(CH2)rNR18—, —(CH2)rNR18C(O)—, —(CH2)rC(O)NR18—, —(CH2)rNR18C(O)O—, —(CH2)rNR18C(O)NR18—, —(CH2)rNR18C(O)NR18O— (in which the groups R18 are the same or different), —(CH2)rO—, —(CH2)rSO3—, or, optionally in combination with B1, a valence bond and r is from 1 to 12 and R18 is hydrogen or a C1-4 alkyl group;
B1 is a straight or branched alkanediyl, oxaalkylene, alkanediyloxaalkanediyl, or alkanediyloligo(oxaalkanediyl) chain optionally containing one or more fluorine atoms up to and including perfluorinated chains or, if Q or Y1 contains a terminal carbon atom bonded to B1 a valence bond; and
Q is the ionic or ionisable group.
12. A polyionic complex according to claim 11 in which Q is a cationic group Q1 which is a group N+R1 3, P+R1 3 or S+R1 2
in which the groups R1 are the same or different and are each hydrogen, C1-4-alkyl or aryl (preferably phenyl) or two or three of the groups R8 together with the heteroatom to which they are attached from a saturated or unsaturated heterocyclic ring containing from 5 to 7 atoms, preferably each R8 being other than hydrogen, most preferably N+R1 3 in which each R1 is C1-4-alkyl, preferably methyl.
13. A polyion complex according to claim 1I in which Q is an anionic group Q2 which is selected from carboxylate, carbonate, sulphonate, sulphate, phosphonate or phosphate, preferably a monovalent group, more preferably a sulphonate group.
14. A polyion complex according to any of claims 1 to 10 in which the cationic monomer is diallyl dialkyl ammonium halide, preferably diallyl dimethyl ammonium chloride.
15. A polyion complex according to any preceding claim in which the nonionic monomer has the general formula VIII
Y2 R14 VIII
in which Y2 is an ethylenically unsaturated polymerisable group selected from
CH2═C(R19-CH2—O—, CH2═C(R19)—CH2OC(O)—, CH2═C(R19)OC(O)—, CH2═C(R19)—O—, CH2═C(R19)CH2OC(O)N(R20)—, R21OOCCR19═CR19C(O)—O—, R19CH═CHC(O)O—, R19CH═C(COOR21)CH2—C(O)—O—,
wherein:
R19 is hydrogen or a C1-4 alkyl group;
R20 is hydrogen or a C1-4 alkyl group or R20 is R14;
R21 is hydrogen or a C1-4 alkyl group or R21 is R14;
A2 is —O— or NR20—;
K2 is a group —(CH2)8OC(O)—, —(CH2)8C(O)O—, —(CH2)8OC(O)O—, —(CH2)8NR22—, —(CH2)8NR22C(O)—, —(CH),C(O)NR22—, —(CH2)8NR22C(O)O—, —(CH2)8OC(O)NR22—, —(CH2)8NR22C(O)NR22— (in which the groups R22 are the same or different), —(CH2)8O—, —(CH2)8SO3—, or a valence bond and s is from 1 to 12 and R22 is hydrogen or a C1-4 alkyl group; and
R14 is an optically substituted C1-24-alkyl or -alkenyl group, optional substituents being hydroxyl groups; halogen atoms; alkoxy and oligo-alkoxy groups, in which the alkoxy groups have 1-6, preferably 2 or 3 carbon atoms; aryl groups, preferably optionally substituted phenyl groups (optional substituents in a phenyl group being hydroxyl groups, halogen atoms or alkyl groups); acyl groups, especially C1-6-alkanoyl groups; acyloxy groups, especially C1-6-alkanoyloxy groups; or acylamino groups, especially C1-6-alkanoyl amino; in any ofwhich alkanoyl groups there maybe substituents selected from halogen atoms and hydroxyl and alkoxyl groups.
16. A polyion complex according to claim 15 in which R14 is C4-18-unsubstituted alkyl.
17. A polyion complex according to any preceding claim, when fully swollen in water, has viscoelastic properties (determined using a variable torque oscillation test (80 rN.m) using a TA instrument CSL-100 rheometer fitted with 6 cm 2° cone at 37° C.), G1 (elasticity modulus) in the range I to 1000 and G″ (viscous modulus) in the range 1.5 to 1000.
18. A composition comprising a polyion complex according to any preceding claim and a liquid absorbed in the polyion complex.
19. A composition according to claim 18 in which the liquid is aqueous.
20. A composition according to claim 19 in which the liquid is free of organic solvent.
21. A composition according to any of claims 18 to 20 comprising an active agent selected from pharmaceutically active agents and diagnostic agents.
22. A method in which a solution of an anionic polymer having an overall anionic charge and a cationic polymer having an overall cationic charge together in a solvent system comprising a first solvent and an inorganic salt which is water-soluble and formed of monovalent metal ions and monovalent counterions, in solution, is gelled by contact with water, whereby the ions of the inorganic salts become dissociated from the polymer and extracted from the gel formed by electrostatic attraction between polymer bound cationic groups and polymer bound anionic groups, and is characterised in that at least one of the cationic and anionic polymers comprises zwitterionic groups.
23. A method according to claim 22 in which said first solvent is an organic solvent, preferably comprising a ketone or an alcohol.
24. A method according to claim 22 or claim 23 in which said solvent system comprises first and second solvents which are miscible under the conditions of the process.
25. A method according to claim 24 in which the said second solvent is water.
26. A method according to claim 24 or claim 25 in which the ratio of first to second solvent is in the range 2:1-1:10, preferably 1:1-1:5.
27. A method according to any of claims 22 to 26 in which the organic salt is a halide of an alkali metal, preferably a chloride or bromide of sodium or potassium, more preferably sodium chloride.
28. A method according to any of claims 22 to 27 having any of the features of claims 1 to 16 .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/341,565 US20030152547A1 (en) | 1998-11-13 | 2003-01-14 | Anionic-cationic polyion complexes comprising zwitterionic monomer component |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98309345 | 1998-11-13 | ||
EP98309345.1 | 1998-11-13 | ||
US09/831,753 US6524569B1 (en) | 1998-11-13 | 1999-11-12 | Anionic-cationic polyion complexes comprising zwitterionic monomer component |
US10/341,565 US20030152547A1 (en) | 1998-11-13 | 2003-01-14 | Anionic-cationic polyion complexes comprising zwitterionic monomer component |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1999/003787 Continuation WO2000029481A1 (en) | 1998-11-13 | 1999-11-12 | Anionic-cationic polyion complexes comprising zwitterionic monomer component |
US09/831,753 Continuation US6524569B1 (en) | 1998-11-13 | 1999-11-12 | Anionic-cationic polyion complexes comprising zwitterionic monomer component |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030152547A1 true US20030152547A1 (en) | 2003-08-14 |
Family
ID=8235165
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/831,753 Expired - Lifetime US6524569B1 (en) | 1998-11-13 | 1999-11-12 | Anionic-cationic polyion complexes comprising zwitterionic monomer component |
US10/341,565 Abandoned US20030152547A1 (en) | 1998-11-13 | 2003-01-14 | Anionic-cationic polyion complexes comprising zwitterionic monomer component |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/831,753 Expired - Lifetime US6524569B1 (en) | 1998-11-13 | 1999-11-12 | Anionic-cationic polyion complexes comprising zwitterionic monomer component |
Country Status (11)
Country | Link |
---|---|
US (2) | US6524569B1 (en) |
EP (1) | EP1141124B1 (en) |
JP (1) | JP4790125B2 (en) |
CN (1) | CN1129646C (en) |
AT (1) | ATE258960T1 (en) |
AU (1) | AU745461B2 (en) |
CA (1) | CA2346862C (en) |
DE (1) | DE69914634T2 (en) |
ES (1) | ES2212648T3 (en) |
HK (1) | HK1040408B (en) |
WO (1) | WO2000029481A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070194275A1 (en) * | 2004-03-11 | 2007-08-23 | Gen Masuda | Liquid composition containing no solvent |
US20080201536A1 (en) * | 2007-02-16 | 2008-08-21 | Seagate Technology Llc | Near instantaneous backup and restore of disc partitions |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4790125B2 (en) * | 1998-11-13 | 2011-10-12 | バイオコンパテイブルズ・ユーケイ・リミテツド | Anionic-cationic polyion complex comprising a zwitterionic monomer component |
US6709551B2 (en) * | 2001-12-17 | 2004-03-23 | Ondeo Nalco Company | High molecular weight cationic and anionic polymers comprising zwitterionic monomers |
ATE486613T1 (en) | 2002-03-07 | 2010-11-15 | Biocompatibles Uk Ltd | BLOCK COPOLYMERS COMPLEXED WITH NUCLIC ACID |
EP1556090A1 (en) * | 2002-09-25 | 2005-07-27 | Biocompatibles UK Limited | Polymer compositions for administration to animals |
EP2269580A3 (en) | 2004-09-07 | 2011-11-09 | Biocompatibles UK Limited | Compositions comprising camptothecins in microspheres |
JP2006249148A (en) * | 2005-03-08 | 2006-09-21 | Kazuhiko Ishihara | Electrostatic-coupling type complex composition and adhesive material for living body using the composition |
US8007831B2 (en) | 2006-02-10 | 2011-08-30 | Biocompatibles Uk Limited | Loading of hydrophobic drugs into hydrophilic polymer delivery systems |
CN100513445C (en) * | 2007-08-14 | 2009-07-15 | 广州天赐高新材料股份有限公司 | Amphoteric ionic polymer for hair styling, preparation method and application thereof |
AU2009321621B2 (en) | 2008-12-02 | 2013-06-13 | Biocompatibles Uk Limited | Pancreatic tumour treatment |
US8980437B2 (en) | 2009-08-24 | 2015-03-17 | Basf Se | Use of polyelectrolyte complexes for producing polymer foils with oxygen-barrier properties |
WO2012070031A1 (en) * | 2010-11-26 | 2012-05-31 | University Of The Witwatersrand, Johannesburg | Polymeric matrix of polymer-lipid nanoparticles as a pharmaceutical dosage form |
US9395277B2 (en) * | 2011-12-06 | 2016-07-19 | Kodak Alaris Inc. | Self-adjusting audio detection of medium jam |
AU2018306908A1 (en) * | 2017-07-24 | 2020-02-20 | Rohm And Haas Company | Mixed-charge polymers |
KR20200124163A (en) * | 2019-04-22 | 2020-11-02 | 삼성디스플레이 주식회사 | Rollable display device |
CN110251736B (en) * | 2019-06-28 | 2022-02-18 | 南京理工大学 | Zwitterionic polymer brush lubricant and preparation method thereof |
CN115212343A (en) * | 2022-05-19 | 2022-10-21 | 季华实验室 | A kind of vascular intervention drug-loaded gel embolizing agent and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6524569B1 (en) * | 1998-11-13 | 2003-02-25 | Biocompatibles Uk Limited | Anionic-cationic polyion complexes comprising zwitterionic monomer component |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2780163B2 (en) * | 1989-02-26 | 1998-07-30 | 互応化学工業株式会社 | Hairdressing resin composition and aerosol foam-type soap-free composition using the same |
CA2112411C (en) | 1991-07-05 | 2001-01-02 | Roderick W. J. Bowers | Polymeric surface coatings |
JPH07238124A (en) | 1994-03-01 | 1995-09-12 | Nippon Oil & Fats Co Ltd | Platelet-fusing material |
JPH08165491A (en) * | 1994-12-16 | 1996-06-25 | Lion Corp | Composite of polymer with anionic surfactant |
FR2749506B1 (en) * | 1996-06-07 | 1998-08-07 | Oreal | DETERGENT COSMETIC COMPOSITIONS FOR HAIR USE AND USE |
JPH10245325A (en) * | 1997-03-03 | 1998-09-14 | Shiseido Co Ltd | Hair setter composition |
-
1999
- 1999-11-12 JP JP2000582462A patent/JP4790125B2/en not_active Expired - Fee Related
- 1999-11-12 AU AU10659/00A patent/AU745461B2/en not_active Ceased
- 1999-11-12 DE DE69914634T patent/DE69914634T2/en not_active Expired - Lifetime
- 1999-11-12 CN CN99813168A patent/CN1129646C/en not_active Expired - Fee Related
- 1999-11-12 CA CA002346862A patent/CA2346862C/en not_active Expired - Fee Related
- 1999-11-12 WO PCT/GB1999/003787 patent/WO2000029481A1/en active IP Right Grant
- 1999-11-12 US US09/831,753 patent/US6524569B1/en not_active Expired - Lifetime
- 1999-11-12 HK HK02100120.1A patent/HK1040408B/en not_active IP Right Cessation
- 1999-11-12 AT AT99954247T patent/ATE258960T1/en not_active IP Right Cessation
- 1999-11-12 EP EP99954247A patent/EP1141124B1/en not_active Expired - Lifetime
- 1999-11-12 ES ES99954247T patent/ES2212648T3/en not_active Expired - Lifetime
-
2003
- 2003-01-14 US US10/341,565 patent/US20030152547A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6524569B1 (en) * | 1998-11-13 | 2003-02-25 | Biocompatibles Uk Limited | Anionic-cationic polyion complexes comprising zwitterionic monomer component |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070194275A1 (en) * | 2004-03-11 | 2007-08-23 | Gen Masuda | Liquid composition containing no solvent |
EP1724290A4 (en) * | 2004-03-11 | 2007-10-03 | Nisshin Spinning | LIQUID COMPOSITION CONTAINING NO SOLVENT |
US20080201536A1 (en) * | 2007-02-16 | 2008-08-21 | Seagate Technology Llc | Near instantaneous backup and restore of disc partitions |
Also Published As
Publication number | Publication date |
---|---|
EP1141124B1 (en) | 2004-02-04 |
DE69914634T2 (en) | 2004-09-23 |
EP1141124A1 (en) | 2001-10-10 |
AU745461B2 (en) | 2002-03-21 |
AU1065900A (en) | 2000-06-05 |
ATE258960T1 (en) | 2004-02-15 |
JP2002530456A (en) | 2002-09-17 |
WO2000029481A1 (en) | 2000-05-25 |
JP4790125B2 (en) | 2011-10-12 |
CN1129646C (en) | 2003-12-03 |
CA2346862C (en) | 2009-09-29 |
HK1040408B (en) | 2004-06-18 |
CA2346862A1 (en) | 2000-05-25 |
DE69914634D1 (en) | 2004-03-11 |
HK1040408A1 (en) | 2002-06-07 |
CN1326486A (en) | 2001-12-12 |
ES2212648T3 (en) | 2004-07-16 |
US6524569B1 (en) | 2003-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6524569B1 (en) | Anionic-cationic polyion complexes comprising zwitterionic monomer component | |
US6562330B1 (en) | Therapeutic use of polymers | |
US6251964B1 (en) | Biocompatible compositions | |
Monge et al. | Phosphorus-containing polymers: a great opportunity for the biomedical field | |
US8415266B2 (en) | Catalyst constituent | |
CN103917548B (en) | Biocompatible bionical ampholytes material | |
GB2151244A (en) | Insolubilized biocompatible hyaluronic acid preparations | |
WO2014022501A2 (en) | Strain-promoted crosslinking of peg-based hydrogels via copper-free cycloaddition | |
JP2003511538A (en) | Zwitterionic polymer blend materials | |
DE69233378T2 (en) | Polymeric surface coating compositions | |
WO2024225337A1 (en) | Adhesive composition | |
JPS6379667A (en) | Antithrombogenic material | |
DE19809347A1 (en) | Hemocompatible and bacteria-repellent hydrophilic copolymers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |